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General introduction
Definition of nanoparticles
Engineered Nanomaterials (ENMs) are used in increasing numbers of applications due 
to their physico-chemical properties [1, 2]. The increasing production volume and the 
increasing range of NM-containing products lead to increased likelihood of unintentional 
release. Determined negative side effects at cellular, as well as whole organisms level, 
after exposure have led to serious concerns about NM safety [3, 4].
The term ‘nano’ relates to the Greek word ‘να˜ νος’ (Latin ‘nanus’), meaning “dwarf”. 
Scientifically it is used as a prefix in the international system of units to describe a billionth 
or 10-9 of a unit, e.g. nanometer (nm). As an example, 1 nm is about the size of 3 gold 
atoms aligned in a row. The diameter of the DNA helix measures approximately 3 nm. 
By definition of the European commission, a material is considered a nanomaterial if any of 
its external dimension falls within the nanoscale of 1-100 nm or if the material has internal 
or surface structures within this size range [5].  Hansen et al. further distinguish classes of 
NMs based on the location of the nanoscale structure within a material [6]: 
a) Nanostructured materials in 3 dimensions that make up the bulk material
b) Nanostructured surfaces
c)  Free structures at nanoscale in at least 2 dimensions; they can be surface bound, 
suspended in solids, suspended in liquids or airborne
With their very small size NMs fall within the same size range as biomolecules. These 
include essential proteins necessary for cell growth, DNA, and viruses. NMs are much 
smaller than an average, eukaryotic cell with average sizes between 10- 30·103 nm, e.g. red 
blood cells. To differentiate between naturally occurring particles in the nanometer 
range and those intentionally produced, the definition is further extended. It includes 
the requirement that the decrease to nm scale goes along with a change in the material’s 
property in comparison to the bulk material of the same chemical composition [6]. 
These are the so called Engineered NMs. As we are interested in the interaction of ENMs 
with biological systems, we focus on free nanostructures of category c within this study. 
More specifically, on those that are suspended in water or that are airborne. In addition, 
we limit our investigations to those NMs that fall within the nanoscale in all three 
dimensions to avoid possible overlaps with well-studied structures in the micrometer 
range, e.g. asbestos. We call free 3D nanostructures nanoparticles (NPs).
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Nanoparticle properties and applications
NPs are used in increasing amounts and number of applications due to the described 
differences in physico-chemical properties in comparison to bulk material of the same 
chemical composition [5]. 
The physical properties of NPs are determined by their particulate nature at small size 
scales. They therefore represent a special form of solid matter. The difference in the 
material’s properties in comparison to the bulk material of the same chemical composition 
is due to the increased surface area to volume ratio. A relatively larger part of the atoms or 
molecules making up the free 3D solids are surrounded by a liquid or air phase; in contrast 
to microparticles where a relatively large part of the atoms or molecules in a solid is 
surrounded by molecules or atoms of the same kind.
NPs show large variation with respect to their chemical composition due to different core 
materials and surface modifications. This, in turn, results in differences in their size, charge, 
hydrophilicity, and chemical and biological reactivity. The changes include, but are not 
limited to, electrical and optical properties, increased reactivity due to the increased 
surface area to volume ratio, solubility, melting temperature, and hardness [7-9]. These 
changes allow for many new applications, e.g. as catalysts, in the field of electronics, in 
optical systems, as well as in the medical field for therapy, imaging, and in diagnostics 
[10-14]. Also consumer products such as sportswear, deodorants or sprays for textiles and 
shoes are claimed to contain nanoparticles [15-18]. This huge variety in applications is 
possible due the large variation in the NPs itself. They can consist of different core materials 
(organic and inorganic) and have various surface coatings, leading to differences in their 
charge, hydrophobicity and lipophilicity.
Uptake mechanisms and biological effects
Many of the medical applications are based on the fact that the applied NPs are able to 
enter cells. The negative experiences with microparticles, such as asbestos, and the similar 
size of NP and biological entities taken up by cells, has resulted in serious concerns about 
possible negative side effects of NPs [19-26]. This leads unavoidably to the question about 
their biocompatibility after unintentional exposure. In this context biocompatibility refers 
to “being biologically compatible by not producing a toxic, injurious, or immunologic 
response in living tissue” [27]. In general, four different exposure routes for NPs exist: 
dermal uptake, ingestion, inhalation, and injection of nanomedicine. Inhalation is considered 
the main exposure route during production and handling of NPs, as well as during application 
of NP-containing sprays [16, 18]. 
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Similar to microparticles, NPs have been shown to induce adverse effects at the cellular 
level by interacting with vital cell components, such as the cell membrane. In addition, 
NPs may reach and harm intracellular targets such as mitochondria, the nucleus and DNA. 
NPs may interact with mitochondrial respiration [28], deplete antioxidant species inside 
the cell [29], and bind to DNA [30]. Some NPs have been shown to enter cells and cause 
changes in their morphological structure, leading to decreased cell attachment and 
impaired cell division [31]. Mutagenesis, protein up/down regulation, apoptosis, oxidative 
stress and DNA damage are possible adverse outcomes [32, 33]. In contrast to traditional 
chemicals, NPs generally do not reach the cell interior through passive diffusion but via an 
active uptake process called endocytosis. NP uptake has been shown to take place via an 
energy dependent, therefore active, uptake mechanism. This has been shown through its 
strong decrease at low temperature, when cells are inactivated, or imaging of endocytic 
vesicles [34-39]. This biological mechanism enables eukaryotic cells to take up essential 
biomolecules from the environment, e.g. cholesterol-laden low-density lipoprotein and 
iron-laden transferrin. Endocytosis also includes phagocytosis, a mechanism employed by 
specialized cells of the immune system aimed at the destruction of foreign cells [40]. 
Through this mechanism NPs cross the cell membrane, the natural barrier separating the 
in- and exterior of a cell, allowing for the exclusion of substances [41]. The endocytosis 
mechanisms enable degradable NPs, such as metallic NPs, to induce stronger negative 
side effects than metal ions of the same concentration [21, 42]. Some degradable NPs are 
able to enter cells and release ions at the inside of a cell, resulting in further reactions [43, 
44]. They gain access to the cellular machinery usually unavailable for the same chemicals 
in ionic form. NPs may, therefore, enter through a so called “Trojan horse effect” and 
increase the intracellular bioavailability [42]. Also non-degradable materials described as 
inert in their bulk from, such as gold, may cause negative side effects in vitro and in vivo 
when sized down to NPs. Uptake and possible accumulation in cells (or organisms) causes 
particular concerns due to the effect on internal cellular structures and hindering of 
processes purely through the physical presence (of chemically inert) NPs. Such secondary 
effects may trigger growth of defective living tissues on the long run [31]. NPs may cause 
injury by uptake and nonoxidant paradigms, so without the disturbance of the normal 
redox state of a cell. Such described hazardous effects on the cellular level might also lead 
to repercussion on the individual [45], populations [46] or even entire food webs through 
trophic transfer and biomagnification [47-52].
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Risk assessment of NPs
A risk is defined as the product of exposure and hazard [53, 54]. Both factors for a risk are 
fulfilled in case of NPs due to increased likelihood of exposure and shown adverse effects 
in vitro and in vivo [55-57]. Given the large number of NP variations, extensive and detailed 
testing of all NP variants for their cellular uptake and subsequent toxicity (in vivo) separately 
seems unfeasible. Keeping pace with the development of new NPs and the need to 
predict their potential uptake and possible subsequent negative effects to human health 
and the environment, requires fast and inexpensive risk assessment. Models and the 
construction of quantitative structure activity relationships offer unique opportunities for 
risk assessment [58]. Therefore, models that allow for predictions of cellular uptake, based 
on easily measurable NP properties, are highly desirable. Models could allow to categorize 
NPs according to likelihood of uptake and prioritize them for specific testing in the early 
phase of development and before data begin to pile up. This would highly improve and 
speed up the risk assessment of these diverse and fast-developing products [7-9]. Risk 
assessment will benefit from increasing understanding of the mechanism of nanoparticle 
interactions with living cells, more specifically, NP properties and experimental factors 
influencing cellular uptake. Due to the unique endocytic uptake mechanism employed by 
NPs, this new type of emerging chemicals requires new models that take this active 
mechanism into account.
Objectives and outline of the thesis
The aim of this thesis is: First, to identify the (main) NP properties and experimental 
conditions that determine cellular NP uptake. Second, to assess their suitability for 
modelling and third, to construct a model to describe such a relationship.
First, a literature review was conducted in order to determine the physico-chemical NP 
properties, in combination with characteristics of the cellular and extracellular media, 
which govern cellular uptake of NPs (Chapter 2). Then, we explored the effect of NP size, 
which has been identified as the main determinant of NP uptake, and medium composition 
on uptake kinetics into two different types of cells (Chapter 3, Chapter 4). Next, a new 
method to determine the possible dissolution of the silver NPs (Ag NPs) during the 
time course of the experiments was developed (Chapter 5). This was followed by the 
comparison of NP uptake rates across studies and the attempt to construct property- 
effect relationships (Chapter 6). The collected data, possible contradictions and implications 
were critically discussed in a synthesis (Chapter 7).
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Abstract
The increased application of nanoparticles (NPs) is increasing the risk of NPs being released 
into the environment. Although many toxicity studies have been conducted, the 
environmental risk is difficult to estimate, because uptake mechanisms are often not 
determined in toxicity studies. Here we review the dominant uptake mechanisms of NPs 
in cells, as well as the effect of NP properties, experimental conditions and cell type on NP 
uptake. Knowledge about NP uptake is crucial for risk assessment, and essential to predict 
the behavior of NP, based on their physical-chemical properties. Important uptake 
mechanisms for eukaryotic cells are macropinocytosis, receptor-mediated endocytosis 
and phagocytosis in specialized mammalian cells. The studies reviewed demonstrate that 
uptake into non-phagocytic cells depends strongly on NP size, with an uptake optimum 
at an NP diameter of about 50 nm. Increasing surface charges, either positive or negative, 
have been shown to increase particle uptake in comparison to uncharged NPs. Another 
important factor is the degree of (homo-) aggregation. Results regarding shape have 
been ambiguous. Difficulties in the production of NPs, with one property changed at a 
time, call for the full characterization of NP properties. Only then it is possible to draw 
conclusions which property affected the uptake.
Keywords
nanoparticles, bioaccumulation, cellular uptake, endocytosis, particle properties
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Introduction
Nanomaterials (NMs) are defined by common consensus as particles with dimensions 
from 1 nm up to 100 nm (nanotechnology), even though “there is no scientific evidence 
to support the appropriateness of this value” [1]. Their characteristics differ from those of 
macroscopic bulk material of the same chemical composition. In nanomedicine, NMs are 
defined as particles with dimensions up to 1000 nm [2]. NMs can be further divided into 
three categories as proposed by Hansen et al. [3], who pointed out that clarification of the 
terminology is needed and proposed a new categorization of NM based on the location 
of the nanostructure in the material. They differentiated between three main categories of 
NMs: “1. Materials that are nanostructured in the bulk, 2. Materials that have nanostructure 
on the surface, and 3. Materials that contain nanostructured particles (...) Category III 
contains nanoparticles, which we define as free structures that are nanosized in at least 
two dimensions.” In the present study, we focus on nanoparticles (NPs) belonging to 
category III. Nanomaterials are manufactured because of their physical and chemical 
 characteristics, including electrical, optical, transparency, hardness, and magnetic 
properties. NMs are being used in increasing amounts and applications [4, 5], including 
their use as fillers, coatings on surfaces, gas sensors, carriers for industrial catalysts, as well 
as in electronics, water treatment and environmental remediation [6, 7]. In addition, NMs 
are increasingly used in consumer products [8], as drug delivery systems for therapy [9-11], 
in imaging [12, 13], and in diagnostics [14-16]. Tuning the characteristic properties yields 
great advantages, such as a reduction of side effects by targeted administration, and 
improvement of the detection sensitivity [17, 18].
 Despite these advantages, possible adverse effects of NMs need to be considered, 
preferably during the design phase, so that design options for functionality and safety 
go hand in hand. Adverse effects on human or environmental health may occur as 
a consequence of NMs being released into the environment, for example during the 
production, transport, usage or waste phases of consumer products [7, 19], leading to 
exposure of humans and the environment. Hazardous effects of NMs have been observed 
at the cellular level, including the generation of reactive oxygen species, lipid peroxidation, 
genotoxicity and mutagenesis, apoptosis or necrosis [20], mitochondrial dysfunction and 
changes in cell morphology [21], with potential repercussions for the individual [22]. 
Potential ecotoxicity has been shown in algae, plants, fungi [23], fish, cladocerans [24], 
and amphibians [7], as well as in bacterial communities [8, 25-27]. Also, NMs could have 
adverse effects on populations [28] and entire food webs, due to trophic transfer and 
biomagnification [29-34]. Larger impacts on the food web dynamics are possible even at 
sub-lethal concentrations, due to changes in the behavior of organisms [35, 36].
 Unfortunately, most of the toxicity and ecotoxicity studies have been conducted 
without determining the uptake mechanism in detail, as was already mentioned by Zhao 
et al [19]. More knowledge about the NM properties and experimental conditions that 
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determine the transport and uptake across cell membranes will improve our understanding 
of their toxicity, and such information might be helpful in designing safer NMs. Toxic 
effects usually originate from the presence of the toxicant inside cells [37]. In addition, 
toxicity is determined by the entrance route and the final intracellular localization [17]. 
Hence, knowledge about NM uptake is crucial to risk assessment studies on NM toxicity.
 It is known that the physical-chemical properties of NMs, in combination with 
 characteristics of the cellular and extracellular media (e.g. protein/lipid adsorption patterns) 
govern the localization in the target cells [38, 39]. Understanding the effects of these 
various properties and characteristics will also be beneficial in pharmacology. Several 
reviews have been published on aspects of uptake in relation to NM properties and 
experimental conditions. Alexis et al. [40] described the factors determining blood residence 
times and organ-specific accumulation of NMs, while Ahsan et al. [41] focused on uptake 
by macrophages. Thevenot et al. [42] reviewed uptake for implant biocompatibility 
purposes. Verma et al. [43] addressed various NM properties but did not include the role 
of experimental conditions in detail. In addition, studies have reviewed the uptake of a 
specific NM such as gold [44, 45]. To the best of our knowledge, however, no overall review 
including the most important factors controlling the cellular uptake of various NPs has 
so far been published.
 Here we (i) review uptake mechanisms of NPs in different cell types, and (ii) identify 
particle properties and experimental conditions that determine transport across cell 
membranes, describing the mechanisms that play an important role in NP uptake. 
Identification and understanding of the factors that determine NP uptake by cells is the 
first step towards predicting NP accumulation and toxicity based on easily measurable 
properties, such as size and zeta potential. Such predictions have already been achieved 
in risk assessment of conventional chemicals [46].
 Ecotoxicity studies are often conducted using whole organisms, [19, 32, 33, 36] so 
mechanistic studies on NP properties and their effects on non-human cell lines are very 
scarce, and many of the cell lines mentioned in the method section are human cell lines. 
Translation of information obtained from human cell lines to cells from other organisms 
should, in principle, be possible. Pinocytosis, one of the fundamental, vital uptake 
mechanisms included under the broad name of endocytosis, is carried out by most 
[47, 48], essentially all eukaryotic cells [49, 50], as is clathrin-mediated endocytosis [51]. 
Receptor-mediated endocytosis is also known to be common to virtually all eukaryotic 
cells, except the mature erythrocyte [52]. Some researchers have gone a step further and 
stated that endocytosis, which is, for example, responsible for nutrient uptake into cells 
[53], exists at least across most [54, 55] if not all eukaryotic cells [56]. Thus, endocytosis is 
ubiquitous in all eukaryotic cells, enabling comparison of results from different cell lines. 
Humans can come into contact with NPs by direct exposure, e.g. during handling or use 
of NP-containing products, or indirectly through the food chain. Since biomagnification 
of NPs has been suggested [57, 58] and some evidence for accumulation within the 
21
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terrestrial food chain has been presented [30], this route of human exposure should be 
taken into consideration in modeling. Combining modeling and empirical studies allows 
for a cost- and time-effective risk assessment of NPs.
Methods
The literature search was conducted via Web of Science, Google Scholar and Scopus, 
using the following key words: nanoparticles, (size-dependent) cellular uptake, endocytosis, 
particle properties, biodistribution, virus and bacteria entry, macrophages, asbestos, 
fine dust. The search resulted in over 100 publications, though many of them concerned 
toxicity rather than accumulation. The papers cover a broad range of disciplines, including 
biomedical and chemical engineering, environmental science, materials chemistry, medicine, 
pathology, microbiology as well as particle and fiber toxicology. The articles address 
many different cell lines, both from exchanging and non-exchanging organs, such as 
HeLa, SNB19, STO, A375, A549, Jurkat, and different phagocytes. Nearly 30 different cell 
lines were used in the various studies. The articles also cover a broad range of NP types 
(approx. 10) such as latex beads, silica particles, hydrogels and various metal NPs (gold, 
silver, iron) with a variety of surface modifications. Information on the cell lines and NP 
types used can be found in Supplemental Data, Table S 2.1. Data presented in Table 2.2, 
Table 2.1, and Table S 2.1 are directly taken from the corresponding references. If the sizes 
are given for single nanoparticles and no measurement of aggregation was conducted, 
the concept of primary particle size is assumed to be valid. If no values were given for 
the surface area (SA) and volume (V), the data provided on the diameter and length of 
the particles were used to calculate them, assuming a spherical or cylindrical shape. 
The most important prerequisite for the selected studies was that one NP property had 
been changed at a time and the respective values are presented in the article as this 
allows the property responsible for a change in NP uptake to be identified. Due to the 
limited number of studies in which only one particle characteristic was changed at a time, 
the only further restriction placed on the literature used for the present study was the 
description of the pathway of uptake.
Table 2.1   Particle properties and their effect on nanoparticle (NP) uptake into  
phagocytic cells.
Determinant Phagocytosis Reference
Ligand Increase [59]
Hydrophilicity Decrease [60-63]
Mechanical flexibility Rigid > soft, flexible [64]
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Table 2.2   Summary of particle properties and experimental conditions and  
their effect on nanoparticle (NP) uptake into cellsa
Receptor-mediated endocytosis
Mechanism Phagocytosis Macropinocytosis Clathrin-mediated Caveolae-mediated Reference
Size [nm] Ligand-induced, particulate 500-1000 Non-specific 100-5000 Vesicles approx. 120 Vesicles approx. 80 [50, 76-80]
Cell type Specialized mammalian Non-specialized eukaryotic
Sphere ø [nm] 50>100>200>500, 1000 not taken up  
Optimum at 50
150>300, 150>500
[73]
20>200 [74, 81-86]
300>150, 500>150 [75]
Shape, ø and L [nm],  
V [µm3], SA [µm2]
ø 150,                         L 450, V 7.9·10-3, SA 2.5·10-1 >ø 200, L 200, V 6.3·10-3, SA 1.9·10-1 [87]
ø 150, L 450,                         V 7.9·10-3, SA 2.5·10-1 >ø 100, L 300, V 2.4·10-3, SA 1.1·10-1 (AR= const) 
2000>4000>8000 in vivo; 
1800>2500>3000 in vitro (const. ø)
ø 74, V 212.2·10-6, SA 17.2·10-3 >ø 14, V 1.4·10-6,  
SA 0,6·10-3 >ø 14, L 40, V 6.2·10-6, SA 2.1·10-3 >ø 14, L 74, V 11.4·10-6,  
SA 3.6·10-3  
[81, 88]
ø 50, V 6.6·10-5, SA 7.9·10-3 >ø 14, V 1.4·10-6, SA 0,6·10-3 >ø 20, L 30,  
V 9.4·10-6, SA 2.5·10-3 >ø 14, L 50, V 7.7·10-6, SA 3.5·10-3 >ø 7, L 42,  
V 6.2·10-6, SA 0.6·10-3
[82]
ø 80-150 = ø 80-150,  L 400-1000 ø 100, L 450, V 35.3·10-4, SA 15.7·10-2>ø 
100, L 240, V 18.9·10-4, SA 9.1·10-2>ø 
100, V 5.2·10-4, SA 3.1·10-2
ø 80-150 >ø 80-150, L 400-1000 [89, 90]
Charge/ ζ-potential [mV]
Positive Increase
35>25>15
Increase
35>25>15
[75]
[91]
Negative Increase
-40>-25>-15
-15>-25>-40
-43.10>-16.26
[75, 92] 
[93]
Pos. vs. neg. Pos. > neg. Pos. > neg.
+32.2±8.19
>-26±1
-42.46>+41.59
[40, 75, 93-95]
Functional group
NH2 Increase [40, 96-98]
COOH Increase Increase [96]
Decrease, increase [99]
OH Increase [100]
Opsonization/  
presence of serum
No change [101-103]
Increase [103]
Decrease Decrease, highest for most hydrophobic NP [104]
a The size of the NPs is defined as the diameter; the surface area is given in µm2 and the volume in µm3. Volume 
and surface area (SA) are calculated assuming spherical shape or rod-shaped NPs. In the latter case, values are 
calculated with the formula for cylinders when only diameter and length are given in the literature, as V=Πr2L; SA= 
2ΠrL+ 2Πr2; where r represents the radius of the particle, L the length (comparable to the height of a cylinder) in 
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Table 2.2   Summary of particle properties and experimental conditions and  
their effect on nanoparticle (NP) uptake into cellsa
Receptor-mediated endocytosis
Mechanism Phagocytosis Macropinocytosis Clathrin-mediated Caveolae-mediated Reference
Size [nm] Ligand-induced, particulate 500-1000 Non-specific 100-5000 Vesicles approx. 120 Vesicles approx. 80 [50, 76-80]
Cell type Specialized mammalian Non-specialized eukaryotic
Sphere ø [nm] 50>100>200>500, 1000 not taken up  
Optimum at 50
150>300, 150>500
[73]
20>200 [74, 81-86]
300>150, 500>150 [75]
Shape, ø and L [nm],  
V [µm3], SA [µm2]
ø 150,                         L 450, V 7.9·10-3, SA 2.5·10-1 >ø 200, L 200, V 6.3·10-3, SA 1.9·10-1 [87]
ø 150, L 450,                         V 7.9·10-3, SA 2.5·10-1 >ø 100, L 300, V 2.4·10-3, SA 1.1·10-1 (AR= const) 
2000>4000>8000 in vivo; 
1800>2500>3000 in vitro (const. ø)
ø 74, V 212.2·10-6, SA 17.2·10-3 >ø 14, V 1.4·10-6,  
SA 0,6·10-3 >ø 14, L 40, V 6.2·10-6, SA 2.1·10-3 >ø 14, L 74, V 11.4·10-6,  
SA 3.6·10-3  
[81, 88]
ø 50, V 6.6·10-5, SA 7.9·10-3 >ø 14, V 1.4·10-6, SA 0,6·10-3 >ø 20, L 30,  
V 9.4·10-6, SA 2.5·10-3 >ø 14, L 50, V 7.7·10-6, SA 3.5·10-3 >ø 7, L 42,  
V 6.2·10-6, SA 0.6·10-3
[82]
ø 80-150 = ø 80-150,  L 400-1000 ø 100, L 450, V 35.3·10-4, SA 15.7·10-2>ø 
100, L 240, V 18.9·10-4, SA 9.1·10-2>ø 
100, V 5.2·10-4, SA 3.1·10-2
ø 80-150 >ø 80-150, L 400-1000 [89, 90]
Charge/ ζ-potential [mV]
Positive Increase
35>25>15
Increase
35>25>15
[75]
[91]
Negative Increase
-40>-25>-15
-15>-25>-40
-43.10>-16.26
[75, 92] 
[93]
Pos. vs. neg. Pos. > neg. Pos. > neg.
+32.2±8.19
>-26±1
-42.46>+41.59
[40, 75, 93-95]
Functional group
NH2 Increase [40, 96-98]
COOH Increase Increase [96]
Decrease, increase [99]
OH Increase [100]
Opsonization/  
presence of serum
No change [101-103]
Increase [103]
Decrease Decrease, highest for most hydrophobic NP [104]
the case of rod-shaped particles. The mechanisms are allocated based on information from the references in the 
last column. If no differentiation between macropinocytosis and receptor-mediated endocytosis is recorded, the 
results are not allocated to a specific mechanism, but the columns are merged. Higher uptake for a defined NP in 
comparison with another is denoted with >.
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Results and discussion
Mechanisms for the uptake of particles into cells
Cell membranes tend to be impermeable to many large particles [65, 66]. Particles can 
only cross the membrane if they are at most 10-30 nm in size [67] (see the more detailed 
discussion below). The cell membrane acts as a barrier separating the external environment 
from the inside of the cell, allowing substances to be concentrated in cells or excluded 
from cells [68]. One mechanism to overcome this barrier is endocytosis. This mechanism is 
exploited by viruses [66, 69-71], which have therefore become a valuable tool to study 
endocytosis [69]. Endocytosis and diffusion have been proposed as mechanisms for the 
uptake into cells of NPs with similar sizes as viruses [63, 72-75].
 Endocytosis is the uptake of particulate matter, such as proteins and other nutrients, 
into eukaryotic cells via enclosure by the cell membrane. It is also exploited by these cells 
for the clearance of cell debris and foreign cells from the body. Endocytosis has been 
defined as “the de novo production of internal membranes from the plasma membrane 
lipid bilayer” [76]. Several forms of endocytosis are distinguished, based on the substance 
to be internalized (see Figure 2.1).
 Opsonized particulate substances and small solute volumes are internalized by a 
mechanism called phagocytosis [69]. Opsonins are small molecules that enhance binding 
in phagocytosis, e.g. antibodies [105]. Particles in large amounts of solute, on the other 
hand, are taken up by a process termed pinocytosis. Pinocytosis can be further divided 
into macropinocytosis [100] and receptor-mediated endocytosis (RME) [63, 73, 74, 82]. In 
view of the large differences between phagocytosis and non-phagocytosis, the results of 
the different studies have been discussed separately below according to the mechanism 
investigated.
Figure 2.1  Proposed uptake mechanisms of nanoparticles (NPs). Depicted are from left 
to right: Uptake of a large particle by phagocytosis, liquid internalization with included 
particles by macropinocytosis, specific binding of ligands to cell surface receptors and 
subsequent receptor-mediated endocytosis, diffusion of NPs trough the lipid double layer 
forming the cell membrane, including transporter-/channel proteins.
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Phagocytic cells are found in all kinds of organisms, ranging from unicellular organisms, 
where phagocytosis represents a form of feeding [106], to complex multi-cellular animals 
[107]. In animals, phagocytosis is part of the immune defense and is typically restricted to 
specialized cells, such as macrophages, monocytes and neutrophils. Phagocytic cells 
specialize in the uptake and degradation of foreign (infectious) cells, e.g. bacteria and cell 
debris and apoptotic cells belonging to the organism itself [108] with a diameter between 
0.5 µm and 10 µm. Phagocytosis is a ligand-induced process [80]. In addition to phagocytosis, 
this cell type also uses pinocytosis. Non-phagocytic cells make use of endocytosis to take 
up small essential nutrients (e.g. cholesterol-laden low-density lipoprotein and iron-laden 
transferrin) [50]. Pinocytosis, the mechanism responsible for the uptake of soluble substances, 
can be divided into different processes according to the size of the vesicle and the protein 
involved in vesicle formation. The four mechanisms will be described subsequently.
 Macropinocytosis: a non-specific mechanism by which fluid contents are taken up in 
the same concentration as in the surrounding medium [109]. The vesicle size is 100 nm to 
5 µm [110]; Clathrin-mediated endocytosis (CME): receptor-mediated endocytosis with 
vesicle sizes of ~120 nm [50, 110]; Caveolae-mediated endocytosis: uptake by RME of vesicles 
of ~80 nm in size [110]; Clathrin- and caveolin-independent endocytosis with vesicles of 
approximately 50 nm. Several clathrin and caveolin independent pathways exist [50, 76, 
79], but these are not discussed any further discussion here, as this uptake pathway was 
not examined in any of the studies discussed here.
 The maximum dimensions of vesicles formed for each pathway are not definitive, but 
their dimensions are likely to be limited to allow internalization of confined cargo sizes 
[111]. The sizes of vesicles differ for each species and cell type and depend on the cargo 
size [73, 112], be it NPs or viruses [70, 71]. Therefore, a maximum NP size for internalization 
can be assumed to exist. Particles above a size limit of 200 nm will not be internalized via 
a single clathrin-coated vesicle [51] or can presumably hardly be internalized via classical 
endocytosis [111].
 Macropinocytosis is a constitutive process occurring continuously and irrespective of 
the cell needs in highly ruffled regions of the plasma membrane. Ruffles trap the 
surrounding medium, including solutes, when their tip bends back towards the cell 
surface. Materials adsorbed onto the cell membrane can be taken up as well. This 
mechanism is called adsorptive macropinocytosis [79].
 Receptor-mediated endocytosis is well studied and plays an important role in the 
study of non-phagocytic uptake. RME allows different types of ligands, such as toxins, 
cholesterol-carrying proteins, vitamins and iron transport proteins, as well as hormones 
and growth factors [113], to enter cells via the binding of specific receptors localized on 
the cell membrane [50]. RME allows the uptake of specific macromolecules from the 
surrounding medium in a concentrated form [79]. RME is also exploited by viruses to enter 
host cells, avoiding to leave evidence of entry (viral glycoproteins) on the outside of the 
cell for detection by the immune defense [66]. To be able to enter, viruses first bind to the 
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surface of a cell in order to concentrate on the cell surface or to induce transmission of cell 
signals for endocytosis [66]. Whether RME or another type of endocytosis takes place is 
determined, among other factors, by the particle size [69]. For particles, the rate of RME is 
determined by interplay of the decrease in free energy required to drive the cargo into the 
cell, the amount of available binding sites and the wrapping time [114]. Nanoparticle 
uptake by endocytosis is a complex interplay of the energy release by the number of 
bound receptors, the number of vesicles that can be formed from the membrane, receptor 
diffusion towards the attached particle and time to complete this process. For large NPs, 
allowing only one particle to be taken up per vesicle, attachment occurs to numerous 
receptors at a time, resulting in a major change in free energy. A larger contact area with 
the cell membrane for elongated particles will also lead to a larger decrease in the free 
energy [114], but at the same time to less available binding sites for other particles [81]. 
Large particles will require more time to complete wrapping [82, 114]. For small particles, 
several NPs can be taken up in one vacuole, but energy release is weaker because only 
single attachment sites exist. Since a local decrease in the Gibbs free energy is required to 
induce membrane wrapping a minimum size for a single particle at a given ligand density 
must exist, otherwise endocytosis is energetically impossible [115]. Uptake is only initiated 
after a certain number of receptors have been triggered. If the change in free energy is too 
small, membrane wrapping will not be induced [114].
 In most studies reviewed, the NPs were larger than the reported size cutoff for 
diffusion. In addition, the uptake mechanisms were determined in each study and were 
reported to be phagocytosis or pinocytosis. Therefore, diffusion will only be discussed 
here shortly. Whether or not non-endocytic uptake mechanisms, such as diffusion or 
active transport, can also be exploited by NPs is under debate [67]. Diffusion is the 
movement of molecules from high to low concentration and takes place for small, 
hydrophobic, uncharged molecules such as oxygen or carbon dioxide. Lipid soluble 
substances, e.g. alcohols, are also able to diffuse through the membrane. Water-soluble 
molecules pass through the membrane passively via pores in a process called facilitated 
diffusion. The pores allow only molecules of a certain size range and electrical charge to 
cross the membrane. For molecules too large or too specialized, carrier molecules can aid 
to pass the membrane actively against the concentration gradient [49]. A study by Geiser 
et al. [72] showed that particles (78, 200 and 1000 nm) taken up by cells were not 
membrane bound, indicating transport via pores or diffusion as a potential route. However, 
charged molecules could not simply pass through the plasma membrane by diffusion 
and particles had to be 10-30 nm in size, the size of a channel pore, in order to allow 
movement via such channels [67]. Nanoparticle transport by transporters was considered 
unlikely due to the high specificity of the transporter structure. A plasma membrane that 
is not clearly distinguishable around NPs is not enough evidence for diffusion being 
accepted as a viable cellular uptake route for NPs [67]. In addition, a size cutoff of 1.47 nm 
diameter for organic chemicals [116] and 4.8 nm diameter for spherical proteins have been 
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reported [117, 118]. This diameter was calculated [117, 118] from the borderline for proteins 
to cross bacterial cell wall by diffusion given as 50 kDa [119]. The latter study concludes 
that only small uncharged hydrophilic molecules with mean radii below 2.5 nm were able 
to pass the wall of two bacterial species. Chain lengths of hydrophobic chemicals longer 
than 5.3 nm have been reported to lead to a lack of accumulation [120].
Nanoparticle properties influencing their uptake
Internalization of nanomaterials in cells is influenced by a large number of physical and 
chemical properties of the specific nanoparticle (Figure 2.2) and the circumstances in the 
exposure medium of the cells. The present study will focus on NP properties that are most 
broadly covered in mechanistic studies: NP size [63, 73-75, 81-85], shape [81, 82, 87-90], 
surface charge [75, 91-95, 121, 122], surface functional groups [40, 96, 97, 100, 123], 
NPs hydrophilicity [61-63, 124-126]. The effect of core composition will not be discussed 
here because the surface characteristics are more important than the bulk characteristics 
since the surface properties determine the protein corona and thereby possibly the 
biological impacts [127]. Experimental conditions (cell type, aggregation, opsonization) 
will be discussed with regard to studies on the effect of NP properties on cellular uptake. 
The major properties of NPs determining interaction with cells are depicted in Figure 2.2 
and described consecutively. All values reported are taken directly from literature; 
therefore our results are also based on the assumptions of the researchers. Implications of 
assumptions such as no aggregation or no formation of surface layers are discussed in 
special sections under the effect of experimental conditions determining NP uptake.
 Size. Spherical NPs up to 500 nm in size were taken up by non-phagocytic cells, whereas no 
particles with a diameter of 1000 nm were detected in these cells (Table 2.2). Previous 
research found a strong decrease in bead internalization and in the speed of the larger 
particles in comparison to 50 nm beads [73]. This is in good agreement with the results of 
He et al. [75], who found that several non-phagocytic cells favored the uptake of smaller 
particles. They also found a clear relation between the size and number of gold particles 
being stabilized with citric acid ligands in each HeLa cell. There was an uptake optimum 
for spherical NP of 50 nm [81]. In the resumption of the previously described work, 
the same size optimum was for transferrin-coated gold NPs, independent of cell line [82]. 
This size optimum of 50 nm has been confirmed for various NPs and cell types [74, 83-85]. 
The results of Rejman et al. [73] contradict the “maximum uptake size” assumption, stating 
that beads as large as 500 nm were taken up by caveolae. “Evidently, the actual size of 
single flask-shape caveolae is too small for accommodating particles as large as 500 nm. 
(…) Recruitment of an internalization machinery is needed to accommodate particles 
that extend beyond the actual size of a caveolae domain, which appears possible given 
internalization of bacteria and viruses along this pathway” [73]. This suggests that 
 macropinocytosis can only be a minor mechanism for the internalization of NP, as was 
proven by the use of specific inhibitors.
28
 Lévy et al. [129] doubted that there was a size optimum for uptake as observed in 
several studies [74, 81, 82]. They argued that the units in which the results were given had 
not been considered. An optimum based on the number of particles per cell does not 
necessarily lead to the same optimum in terms of mass [129]. Most of studies have reported 
the number of particles per cell, except Lu et al. [74]. Yue et al [130] expressed inter-
nalization of differently sized NPs by three different units (number of particles per cell, 
particle volume per cell and particle surface area per cell). They showed graphically that 
the size optimum varies depending on the unit. The surface area to volume ratio decreases 
with increasing volume. In addition, the sizes given usually refer to the pure NPs after 
synthesis, but changes might occur during the experiments due to aggregation or 
attachment of serum components might occur. This in turn may have altered the outcome 
of the experiments.
Figure 2.2  Determinants of nanoparticle (NP) interactions with cells as determined by 
experimental conditions (presence of protein and opsonins); shape (spheres, short-long 
rods, cubes and triangles with different aspect ratios), cell type, size, surface chemistry 
and addition of ligands. (modified after Chou et al. [128]). The state of aggregation outside 
the cell is not depicted here, which has been shown to play an important role in NP 
uptake [19].
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The effect of NP size on the uptake into phagocytic cells is less well studied (Table 2.2). 
J774. A1 murine ‘macrophage-like’ cells readily took up both 20 nm and 200 nm COOH- 
modified coated polystyrene beads (PBs), but the smaller PBs were taken up relatively 
faster and more extensively [63]. This contradicts the observation that phagocytic cell 
lines favored the uptake of larger particles [75]. The highest attachment has been observed 
for particles with a longest dimension of 2-3 µm [131], which also represents the largest 
dimension of commonly found bacteria [110]. One possible explanation for those 
contradictions are “the difficulties in controlling the surface charge during the size control 
processes and the lack in surface functionality” [75]. Overall, particle uptake by 
non-phagocytic cells shows a clear trend: uptake increases with particle size to an 
optimum of about 50 nm and decreases for larger particles [73, 81-85]. For phagocytes, 
the uptake is not unequivocally related to particle size.
 Shape and Geometry. The effect of the particle shape of cationic, monodisperse 
cross-linked poly ethylene glycol hydrogel particles on uptake has been studied in HeLa 
cells [87]. Pinocytosis, in parallel non-specific and receptor-mediated, was the determined 
uptake mechanism. The particles consisted of cylinders with different aspect ratios (AR) 
and a constant surface charge. Direct comparison of particles with the same AR showed 
that the ones with a smaller diameter were taken up to a lesser extent than the ones with 
a larger diameter and much larger volume (2.4·10-3 µm3 versus 7.9·10-3 µm3) [87]. Particles 
with a diameter of 150 nm and a length of 450 nm were taken up four times faster by the 
cells than those with a diameter and a length of 200 nm, despite their similar volumes of 
7.9·10-3 µm3 and 6.3·10-3 µm3, respectively. In agreement with this study, other found that 
cellular uptake by non-phagocytic A375 human melanoma cells increased in terms of 
numbers and speed with the aspect ratio of mesoporous silica NP (MSNP) spheres and 
rods of constant diameter [90]. The uptake of rod-shaped gold NPs with citric acid ligands 
and their spherical counterparts into HeLa cells has been compared by Chithrani et al. [81]. 
The same trend of a size optimum that was found for spherical particles was also seen for 
rod-shaped NPs. The larger rods with one dimension of more than 50 nm were taken up 
less than the smaller rods with a length of 40 nm [81]. In contrast to the study by Huang 
et al. [90], an increase in AR led to a decrease in uptake as shown by Chitrani et al. [81]. 
The larger contact area of rod-shaped NPs with the membrane led to a reduction in 
available binding sites [81]. In another study by Chithrani and co-workers, the same trend 
was found for Au NPs coated with transferrin [82]. Wrapping times increased with 
increasing surface area of the transferrin coated NPs [82]. The study by Gratton et al. 
underpins the dependence of internalization kinetics of NPs by HeLa cells on the absolute 
particle size rather than on the AR [87].
 To be able to draw conclusions about the effect of particle shape on uptake despite 
experimental limitations and problems in the production processes of non-spherical NPs, 
modeling of the interplay of receptor-ligand binding and transport time across membranes 
has been performed for single particles and particle cluster [132]. In computer simulations, 
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the volume and ligand density of differently shaped NPs was kept constant. Particles were 
designed as spheres, long and short rods and disks. It was shown that endocytosis can be 
divided into two steps: Membrane invagination and particle wrapping [48]. During the 
first stage, NPs orientated towards the membrane in such a way that ligand-receptor 
binding became largest by maximizing the contact area. This caused the membrane to 
invaginate. The kinetics of the second stage, particle wrapping, were governed by the 
largest local mean curvature leading to a reorientation of shape anisotropic NPs (for 
example rods and disks). One requirement for successful internalization was the release of 
sufficient free energy by ligand-receptor binding to overcome the energy required for 
membrane bending during wrapping [48].
 Clift et al. showed that the rate of uptake of MSNP in fibroblasts with deficient 
phagocytosis decreased with an increase in AR [89]. The uptake mechanism has not been 
determined in the same study as the rate of uptake, but in a previous study. There the 
same kind of particles were shown to be taken up into HeLa cells by clathrin-mediated 
endocytosis [133]. The effect of the cell line on NP uptake is discussed further under the 
section ‘experimental conditions’. The rod shaped particles used by Clift et al. were much 
larger (L 400-1000 nm) than the dimensions of vesicles formed in clathrin-mediated 
endocytosis by fibroblasts. These vesicle sizes are not definitive, but are likely to be limited 
to confined cargo sizes [111]. Uptake curves determined by Clift et al. showed the same 
shape and saturation at the same time point for spherical and tubular MSNP by non-pro-
fessional (sessile) phagocytic chinese hamster ovary cells [89]. At the same time, a tendency 
of tube like NPs to form larger aggregates with a wider size distribution of 955-1480 nm 
than the spherical particles, which had a sharp peak at 712 nm, was reported. This study 
confirms that the concept of primary particle size is not applicable under some 
experimental conditions (see further discussion under the section ‘aggregation’). The 
same might be the case in the environment where ageing and aggregation possibly take 
place before the NPs reach an organism. Contradictory results have been reported for in 
vivo studies: a decrease in AR led to increased cellular uptake, measured as decreased 
circulation times in rodents. In agreement with this, spheres and short particles showed a 
higher uptake in human-derived macrophages in vitro [88].
 The effect of shape on NP uptake using six different geometries (spheres, oblate 
ellipsoids, prolate ellipsoids elliptical disks, rectangular disks and UFOs) in alveolar 
macrophages has been studied by Champion and Mitragotri [134]. The shape was 
described by the angle of tangents of the particle as related to the membrane at the first 
point of contact. Shape rather than size determined the induction of the phagocytosis 
process. Phagocytosis was induced by the formation of a complex actin structure for 
angles smaller than 45 degrees, while spreading of the membrane took place for larger 
contact angles. Size determined whether internalization was successful. When the volume 
of the particle was larger than that of the cell, phagocytosis was not completed [134].
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The AR alone does not offer enough information to draw conclusions about NP uptake, for 
example whether a certain size for vesicular uptake limit can be exceeded (Table 2.2). 
Particles with the same AR may have very different dimensions, such as length, diameter 
or volume, which affect the uptake and have to be considered. The above studies have 
been ambiguous regarding the effect of AR on non-phagocytic uptake. RME has been 
shown to increase with a smaller AR [81]. For macro-pinocytosis or an undefined non- 
phagocytic uptake mechanism, the higher AR led to increased uptake [87]. In phagocytosis, 
uptake increased for smaller AR or stayed the same, depending on the cell type [89]. 
However, it is not clear whether this can be attributed to a change in length or volume, or 
to both. Whether the length or the volume is dominant is difficult to assess, because 
studies where one factor is changed at a time are lacking. The reason appears to be the 
difficult production of spheres and rods with equal chemical composition [82].
Surface charge. Zero surface charges, either by neutral surface groups, e.g. hydroxyl groups, 
or by zwitterionic ligands, have been shown to lead to low cellular uptake compared to 
charged particles [75, 92, 93, 121, 122]. This can be explained by the low NP affinity towards 
the overall negatively charged cell membrane. Zero surface charges cause the hindrance 
of nonspecific protein adsorption [135, 136] and a strong hydration layer via electrostatic 
interaction may be formed [136].
 A positive surface charge has been shown to increase particle uptake, both in 
phagocytes [75, 91, 97] and non-phagocytic cell lines [75, 97]. Positive surface charges 
(NH2) increase cell surface affinity and uptake of NPs in both cell types. The uptake is 
determined by electrostatic attractions towards the slightly negatively charged cell 
membrane [137]. Increase of the NP uptake by macrophages has been observed for 
negative surface charges [75, 92]. For uptake of negatively charged NPs by RME, opposing 
results have been reported. On the one hand increase in cellular uptake was observed 
with increasing charge [93]. On the other hand decreasing uptake was reported by He et 
al. [75]. The possibility of changes in other surface properties during the charge control 
process, such as the hydrophobicity, has to be kept in mind. These might affect the uptake 
into cells as well. At a first glance, an increase of transport of more negatively charged NPs 
across the negatively charged cell membrane seems not logic due to repulsion. However, 
high charges prevent agglomeration and particles with low zeta-potential tend to 
aggregate lowering their uptake rate [19, 138]. Therefore, the uptake was possibly not 
determined by the lower zeta-potential but by the likely bigger size of the formed 
agglomerates. The issue of particle aggregation will be discussed under a separate 
section. When positive and negative surface charges were directly compared, keeping 
other properties the same, positively charged particles were shown to be taken up by 
non-phagocytes more favorably than negatively charged ones [75, 94]. The same finding 
was reported for phagocytes [75, 95].
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In most studies an increase in positive or negative surface charge led to increased NP 
uptake in comparison to less or uncharged NPs. Only one study contradicted with these 
results [75]. In addition, positively charged particles seemed to be taken up more 
extensively compared to negatively charged NPs when the absolute zeta-potential was 
similar [75, 94].
 Surface functional groups. Investigations on the effect of surface functional groups often 
include Poly Ethylene Glycol (PEG), which will be described in the next section on due to its high 
hydrophilicity, the negative carboxyl group (-COOH), neutral functional groups like hydroxyl 
groups (-OH) and the positive amine group (-NH2). Increasing positive surface charge, by 
increasing amounts of amine groups, has been shown to increase uptake of NPs into cells 
for various cell lines, both non- and phagocytic, and various NPs [40, 96, 97, 123].
 Carboxyl (-COOH) functional groups add a negative charge to the NPs and have been 
shown to increase NP uptake in both cell types. The uptake studies were conducted in a 
medium containing protein (fetal calf serum) [96]. This might have a great effect on 
particle uptake as will be described in a later chapter. On the other hand, carboxyl groups 
on dendrimers led to increased residence times in vivo. One possible explanation is the 
resistance to recognition by the immune system through protein adsorption [139]. These 
opposing results can be attributed to other NP properties, such as the hydrophilicity or 
differences in experimental conditions influencing NP uptake and vary widely between 
different studies (in vitro vs. in vivo).
 Increasing uptake has been observed for hydroxyl (-OH) functional groups via a 
non-specific adsorptive uptake route in non-phagocytic cells [100]. Uptake is increased by 
the adsorption of serum proteins onto the negative surface by electrostatic and 
hydrophobic interactions. The negative surface of the NPs under investigation did not 
determine particle uptake, but the outer shell of serum protein [140]. In a similar manner 
ligands incorporated into the NP surface, such as mannosyl, immunoglobin, fibronectin 
lipoprotein, or galactosyl, have been found to increase particle uptake by interaction with 
phagocyte surface receptors [59].
 Hydrophilicity and lipophilicity. Poly ethylene glycol (PEG) is a highly hydrophilic 
molecule. An increase in hydrophilicity led to decreased particle uptake by macrophages 
[61-63, 124], as well as in non-phagocytic HeLa cells [125]. This effect was explained by the 
surfactant properties of PEG [61, 124, 141]. The hydrate shell around the particle hinders the 
adhesion of large molecules. In addition, molecular mobile PEG chains present a steric 
hindrance for binding of opsonins to the particle. Without the binding of opsonins, uptake 
into phagocytes is prevented because the necessary recognition is suppressed. 
Amphipathic polymers showed a very similar effect as PEG. Their hydrophobic properties 
allowed adsorption on the NP’s surface, while their hydrophilic part pointed toward the 
aqueous solution and hindered the adsorption of plasma proteins, leading to expanded 
longevity of the NPs [126]. Another particle property, namely flexibility, also decreased 
phagocytic uptake in comparison to rigid particles [64].
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Experimental conditions determining NP uptake
The experimental conditions found to have the greatest effects on the uptake of NPs will 
be described subsequently. They might explain the observed differences in studies on the 
effect of NP properties on their uptake. The results of uptake or toxicity studies, described 
in the subsequent remaining sections, were retrieved from in vitro experiments using cell 
cultures or unicellular microalgae [142]. Kinetic and sorption studies are done without the 
use of cells [135, 136].
 Cell types. Cell properties have been shown to affect NP uptake. As a result, uptake is 
related to differences between cell types, e.g. phagocytic vs. non-phagocytic, cancer vs. 
normal cells and monocytes vs. macrophages [143]. Cancer cells have been shown to 
express different amounts of receptors on their surface than normal cells. This may affect 
the available binding sites of cargos and their uptake [144, 145]. In addition, the metabolic 
activity of the cells used, may affect particle uptake as has been shown with contradictious 
results [146, 147]. Not surprisingly, small differences across species, in uptake kinetics and 
amount of NPs taken up, are observed [96]. Phagocytes and non-phagocytes have the 
same biological function across all species (see section ‘Mechanisms for uptake of particles 
into cells’), therefore the observed differences between cells of the same endocytosis type 
are rather small and the trend in uptake is the same. Differences can be explained by small 
variations in the composition of the cell membrane, the available surface area and the cell 
volume/size.
 Aggregation. Aggregation plays an important role in determining the mobility, fate, 
persistence and toxicity of NPs [148-151]. It depends on experimental conditions and NP 
properties. Zwitterionic ligands such as phosphoryl choline stabilize NPs, preventing 
aggregation under numerous conditions, such as the presence of negatively or positively 
charged proteins [136]. The absence of nonspecific interaction has also been demonstrated 
for zwitterionic disulfides; it led to increased colloid stability in the presence of salt, 
negatively and positively charged polyelectrolytes as well as positively and negatively 
charged proteins. The stabilization of citrate-capped and zwitterion-capped NPs was 
compared. Stabilization of zwitterions-capped NPs was observed under more experimental 
conditions (proteins and polyelectrolytes) than for citrate capped gold NP [135]. 
Aggregation can be prevented by sonication and shaking. Yet, aggregation may be 
caused by prolonged sonication itself [152]. Shaking of the NPs and cells in solution may 
increase particle uptake into cells due to a higher hitting frequency [142]. Dispersants may 
be used to prevent agglomeration, but their use may alter the bioavailability and uptake 
of NPs [142]. Changes in uptake are caused by increasing amounts of NPs delivered to the 
cell membrane inadvertently by the interaction of lipid-soluble dispersants with the 
membrane. Alternatively, coating of the NPs with the dispersants may alter the interaction 
between the cell surface and the NP. Aggregation is also influenced by the ionic strength 
of the medium and directly influences particle uptake. Compression of the electric double 
layer with increasing ionic strength takes place. The energy barrier of the electrostatic 
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repulsion of two particles of the same charge becomes smaller and the attachment 
probability in turn becomes larger [23].
 Opsonization (marking for ingestion and destruction by a phagocyte [105]). Serum 
proteins can also become present on the surface of NPs when serum is used in the uptake 
experiments, similar to the addition of ligands in the preparation step of NPs. After addition 
of serum, particle uptake by phagocytes has been reported to be indifferent [103], to 
increase [101-103] or to decrease [103], depending on the kind of protein present (Table 2.1). 
These contradictory effects can be explained by the presence of different proteins in the 
medium, by a dynamic change of the protein corona composition over time due to 
protein abundance and affinity [127, 153, 154] and by possible particle opsonization. Lynch 
et al. [155] hypothesize that the subcellular localization of a NP is determined by the 
NP-protein corona, besides by size and shape. Lundqvist et al. found in their studies [127] 
that the corona composition depends on both size and surface properties of the NPs 
(plain polystyrene, carbocyl-modified, amine modified). It is proposed that such “surface 
modifications are able to entirely change the nature of the biological active proteins in the 
corona, and thereby possibly also the biological impacts” [127]. An increasing amount of 
serum present during incubation with non-phagocytic cells causes a decrease in cellular 
particle uptake. The degree of decrease depends on the particles’ hydrophobicity. Increasing 
hydrophobicity increased the effect. The hydrophobicity of the particle controls the 
binding to hydrophobic pockets of bovine serum albumin (BSA). The anionic BSA shows 
greater avidity towards the more hydrophobic NPs and repulsive interaction with the 
negative cell membrane [104]. Serum shows different effects on particle uptake by 
phagocytes [101-103] and can be explained by the kind of proteins present in the medium, 
the protein corona composition and particle opsonization [156, 157]. In addition, the NP 
charge plays a dominant role because proteins can be positively (e.g., lysozymes) or 
negatively (e.g. bovine serum albumins) charged [136]. The differences in NP uptake by 
non-phagocytic cell lines can be explained by various properties of the cells such as 
different binding proteins present at their surface, the charge within and on the cell 
surface and the rate of receptor recycling [47, 144, 158].
Conclusions and recommendation
Our review showed that patterns, albeit sometimes uncertain, are gradually emerging. In 
general the following trends can be observed: Uptake of NPs in non-phagocytic shows an 
optimum at a particle size of around 50 nm, for phagocytes the results are inconclusive. 
Increased charge, either positive or negative favor the uptake in both cell types. When the 
absolute values are comparable, positive charged particles are taken up more extensively. 
Addition of amine- or carboxyl-groups leads to increased uptake as well. With increasing 
hydrophilicity, the uptake decreases. The presence of serum during incubation and 
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whether opsonization takes place have shown all possible effects on uptake. This can be 
attributed to the kind of proteins present. The effect of AR on NP uptake remains unsolved. 
The disparities might be caused by the difficulties in the production of NPs with one phys-
ical-chemical parameter changed at a time, e.g. changing the surface charge might affect 
the hydrophobicity as well. Therefore, to pin down the responsible property, either more 
exact studies only varying one parameter at a time are needed or a multivariate approach 
can be taken. In the latter case, all NP properties that might be changed have to be 
measured and published in the future to give a complete picture of causes and effects.
 In general, several contradictions on data and conclusions from different studies were 
identified in the present study. The limited number of NP properties and widely varied 
experimental conditions tested lead to some uncertainty in the interpretation of the 
results. Information about NP properties determining accumulation is very limited 
compared to data from toxicological studies. Especially, the effect of NP shape on uptake 
remains unresolved. This is due to a lack of commercially available techniques to produce 
non-spherical NPs and limited procedures to obtain NPs with one property changed at a 
time only. The exact reciprocity of shape and the responsible determinant (length, volume 
or surface area) for NPs with constant surface chemistry still require experimental 
investigation. In most studies, it is assumed that particles are not aggregated. The particle 
size is often determined in the pure NP solution and their shelf life is detected. Effects of 
cell growth medium and biomolecules excreted by cells are not considered in those 
cases. Optical techniques like transmission electron microscopy (TEM) or microscopy can 
allow determining whether NPs are aggregated or not [82]. If NP uptake is determined by 
other techniques, aggregation might remain undetected and be reflected in contradictory 
results [159]. The test medium is an important factor determining aggregation. 
Nanoparticles might readily aggregate under high ionic strength [160] or in a nutrient-rich 
culture medium [161]. The occurrence of “agglomeration disqualifies the concept of 
primary particle size” [148]. Therefore, the aggregation state should always be determined 
under conditions as close to the experimental conditions as possible.
 Future developments will benefit most from studies conducted according to 
standardized protocols, regarding cell type and experimental setups, to overcome in-
comparability between studies conducted in different laboratories and unveil more 
information about the underlying mechanism of particle uptake by cells. For detailed 
information about standardized protocols, the reader is directed to a critical review that 
suggests nano-specific modifications of test protocols [142]. Reference materials for NPs 
should be made available to avoid differences of the nominally same end product 
supplied by various manufacturers [26] or when produced by the researcher themselves. 
Particle properties such as size and charge should be measured wherever possible 
because interlaboratory deviations [162] and differences to the data from the supplier 
have been noticed [31, 163, 164]. Standardized test methods would possibly fill knowledge 
gaps and resolve apparent contradictions. On the other hand, standardized tests are 
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unlikely to completely cover the large and continuously growing number of engineered 
NPs. Consequently, extrapolation between different NPs and between different experimental 
conditions is needed. For that, modeling is indispensable.
Supplemental data
Table S 2.1 on cell type and NPs used in the reviewed studies.
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Appendix
Table S 2.1   Information on cell lines, nanoparticle type and serum use of  
the studies reviewed
Cell line NP type & surface coating Use of serum Reference
Blood-drawn human 
neutrophils, human 
macrophage THP1, A549
Block copolymers of EOm-EEn, 
EOm-CLn
yes [88]
HeLa Cross-linked poly(ethylene 
glycol) hydrogels 
yes [87]
L02, HEK 293, 786-O, HFL-I, 
A549, SMMC-7721, H-22
 RhB-CMCNP, RhB-CHNP FCS [75]
CL1-0, HeLa AuNPs with ssDNA FBS [85]
HeLa “Glycovirus” - Quantum Dot 
Conjugated Sugar Ball
no [84]
B 16-F10 mouse melanoma Fluorescent latex beads no [73]
J774.A1 macrophage-like Polystyrene beads FCS [63]
HeLa AuNPs stabilized by citric acid 
ligands
yes [81]
HeLa, SNB19, STO cells Transferrin-coated gold NPs yes [82]
SK-BR-3 Gold and silver NP coated with 
antibodies 
BSA [83]
CHO, human fibroblasts Fluorescein isothiocyanate-
doped MSNs
no [89]
A375 Fluorescent labeled MSNs no [90]
A549 Microemulsion ceria and 
Hydrothermal ceria
FBS [93]
HeLa PLA and mPEG-PLA no [94]
HeLa, MSCs, Jurkat, KG1a magnetic polystyrene particles 
encapsulating magnetite 
nanoparticles  in a hydrophobic 
poly(styrene-co-acrylic acid) shell
FCS [96]
HeLa, MSCs, Jurkat, KG1a Fluorescent-labeled polymeric 
particles
FCS [97]
C10 Amorphous silica particles 
modified with amine groups
no [98]
A549 PAMAM-NH2, PAMAM-OH, 
Polyol-OH
FCS [100]
Kupffer Lecithin-coated polystyrene 
nanospheres
Rat serum, IgG, 
complement C3 
[101]
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Table S 2.1  Continued
Cell line NP type & surface coating Use of serum Reference
Leucocytes Polystyrene latex Dialyzed protein 
fraction of 
human plasma
[102]
HeLa AuNPs, quaternary amine and 
various head groups
FBS [104]
C-166, HeLa, A549 AuNP with monolayer of 
polyanionic DNA
yes [140]
HUVEC, MDA-MB-231 Iron oxide NPs coated with 
alendronate or alendronate-PEG
no [124]
Suspension macrophages Sulfate modified fluorescent 
polystyrene beads with 
multilayers of PLL, CHI and HS, 
modified with PEG
BSA [61]
DC2.4 AuNPs coated with: MUS, MUS 
and OT, MUS and br-OT
both [43]
Bone-marrow-derived 
macrophages from mice
BSA covalently coupled to 
polyacrylamide beads
--- [64]
HeLa FITC-MSNs no [74]
membrane
encloses
particle
vesicle
membrane
encloses
particle
vesicle
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Abstract
The increasing number of nanotechnology products on the market poses increasing 
human health risks by particle exposures. Adverse effects of silver nanoparticles (AgNPs) 
in various cell lines have been measured based on exposure dose after a fixed time point 
but NP uptake kinetics and the time-dependent internal cellular concentration are often 
not considered. Even though knowledge about relevant time-scales for NP uptake is 
essential, e.g. for time- and cost-effective risk assessment through modelling, insufficient 
data is available. Therefore, the authors examined uptake rates for three different AgNP 
sizes (20, 50 and 75 nm) and two tissue culture medium compositions (with and without 
fetal calf serum, FCS) under realistic exposure concentrations in pulmonary epithelial 
16HBE14o-cells. The quantification of Ag in cells was carried out by High Resolution 
Inductively Coupled Plasma Mass Spectrometry. We show for the first time that uptake 
kinetics of AgNPs into 16HBE14o-cells was highly influenced by medium composition. 
Uptake into cells was higher in medium without FCS, reaching approximately twice the 
concentration after 24 hours than in medium supplemented with FCS, showing highest 
uptake for 50 nm AgNPs when expressed on a mass basis. This optimum shifts to 20 nm 
on a number basis, stressing the importance of the measurand in which results are 
presented. The importance of our research identifies that not just the uptake after a 
certain time point should be considered as dose but that also the process of uptake 
(timing) might need to be considered when studying the mechanism of toxicity of 
nanoparticles.
Keywords
Nanoparticle, uptake kinetics, size dependence, internal cellular concentration, serum 
proteins, health and safety effects, biomedicine
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Introduction
Nanoparticles (NPs) are used in increasing amounts and number of applications [1, 2] due 
to their unique physical and chemical properties. Consumer products with NPs include 
toothpaste, wound dressings, antibacterial towels and sportswear, as well as in deodorants 
and in sprays for textiles and shoes [3-6]. Of special interest for consumer products, 
medical applications and industry are silver nanoparticles (AgNPs), attributable, besides 
others, to their antimicrobial properties. Several in vitro studies showed that AgNPs affect 
various cell lines, including phagocytosing cell like THP-1-derived macrophages, and 
serious concerns about toxicological and environmental effects have been raised [7-10].
 So, it can be concluded that adverse effects can occur after contact with NPs. 
Exposure routes include dermal, intestinal and inhalation uptake, whereas injection may 
be used for nano-medical products. Inhalation of AgNPs (aerosols) is possible by 
consumers during product use (e.g. spray applications) or by workers during the 
production and processing of NPs [11]. Also for AgNPs respiratory toxicity was reported in 
various animals’ studies [12-16]. On the long term, the product containing the NPs may 
end up in the environment through wash off, posing a potential risk to human health and 
biota [17]. Unfortunately, effects are often measured after a single fixed time point based 
on exposure dose, neglecting uptake kinetics and the therefore time-dependent internal 
cellular concentration. NP properties, such as size, influence uptake as shown for various 
cell lines in vitro. Unfortunately uptake was detected only after a fixed time point [18-22].
 Small NPs can enter cells after contact via one of the four exposure routes through a 
fundamental biological process called endocytosis as previously summarized [23]. 
Particulate matter, such as proteins and other nutrients, are taken up into eukaryotic cells 
via enclosure by the cell membrane [24]. Endocytosis and is a form of active transport. 
Endocytosis is usually employed by non-phagocytic cells like 16HBE to take up 
biomolecules from the environment. The cell membrane forms itself around the 
molecules/particle to be taken up,  the size of the resulting vesicles depends on the 
presence of ligands and the protein involved in vesicle formation [25]. Macropinocytosis is 
a non-specific mechanism by which the cell surrounding fluid and its content are taken up 
in a concentration as present with vesicles from 100 nm to 5 µm in size [26]. The other 
pathways are receptor-mediated, uptake occurs after binding of a ligand to specific 
receptors in the cell surface, which results in uptake of the ligand in higher concentration 
then in the medium. These pathways are further distinguished by the protein involved in 
vesicle formation. Vesicles in receptor-mediated endocytosis reach sizes up to roughly 80 
nm in diameter (i.d.) (caveolae-mediated) [27] or 120 nm i.d. (clathrin-mediated) [24, 27]. 
Internalized NPs may cause the production of reactive oxygen species due to their effects 
on mitochondrial respiration [28] and antioxidant species might be depleted in the cell 
[29]. Metals in the form of NPs may employ this mechanism and metal ions then may enter 
cells by a so called Trojan horse effect. Especially in the case of soluble metal particles this 
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can result in high levels of the metal in various ionic species inside the cell resulting in 
further reactions [30, 31]. By this mechanism, AgNPs can enter cells and release toxic Ag 
ions inside the cell “bypassing its barriers to “normal”-sized Ag, and then releasing Ag ions 
that damage cell machinery” [32], thereby increasing the intracellular bioavailability of Ag. 
It was shown that AgNPs can induce a higher toxic damage than Ag ions [10, 32]. As 
summarized previously, several experimental conditions may influence NP uptake [23]. 
Especially the presence or absence of serum proteins has been shown to have great 
effects through the formation of a so called protein corona on the NPs surface. Uptake can 
be increased, decreased or remain the same, depending on the type of protein present 
[33-36]. In this study, we aim to determine rates of uptake for different AgNP sizes and cell 
culture medium with and without serum proteins, therefore exposing 16HBE14o-cells to 
NP for different periods of time over 24 hours. We apply NP concentrations of 0.01 µg Ag/
mL that represent  realistic concentrations for short term exposures [37]. This concentration 
is much lower, namely by a factor of up to 10 000, than in some of the existing literature 
where uptake rates have been determined [38, 39]. These data will deliver new insights 
into the effect of NP size on their uptake rate and are required to model and predict NP 
uptake rates based on easily measurable NP properties. Combining of empirical data and 
modelling will be an indispensable tool for time- and cost-effective risk assessment of NPs.
Material and Methods
Nanomaterials
For non-phagocytic cells like 16HBE14o a maximum vesicle size of 80-120 nm has been 
found [24, 27], therefore three differently sized AgNPs were investigated in this study: 20 
nm Citrate BioPure™ Silver, 50 nm Citrate BioPure™ Silver and 75 nm Citrate BioPure™ Silver 
were purchased from NanoComposix Inc (San Diego, CA) in the form of stock dispersion 
with concentrations of 1 mg/mL in aqueous 2 mM citrate buffer. The supplier provided 
detailed information about the NPs characteristics as summarized in Table 3.1. The diameter 
was detected by the manufacturer NanoComposix Inc using transmission electron microscopy 
(TEM) (JEOL 1010 Transmission Electron Microscope), the hydrodynamic diameter trough 
dynamic light scattering (DLS) (Malvern Zetasizer Nano ZS). The material for TEM imaging 
is prepared by drying nanoparticles on a copper grid; samples for DSL measurements are 
undiluted in case of 20 nm AgNPs, and diluted with water by a factor of 10 and a factor of 
20 for 50 nm and 75 nm AgNPs, respectively. According to the supplied information, the 
NPs are stable for at least one year, however, prolonged exposure to light may the change 
the material size. Accordingly, the NPs were always kept out of light as much as possible, 
but light exposure could not be completely prevented during handling.
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Preparation of AgNPs dispersions
Due to the significant effects serum proteins present in tissue culture growth medium 
may have on uptake, these uptake studies were conducted with two types of medium, 
with fetal calf serum (+FCS) and without (w/o) the addition of FCS [34, 35, 40]. The dilutions 
of AgNPs dispersions were performed in complete tissue culture medium (see below), 
either without or with FCS, prior to exposure. Final exposure concentrations of 0.01 µg Ag/
mL were obtained in several steps and pre-dilutions: Per 1 mL medium 10 µL of the NP 
dispersion were added for the first pre-dilution and mixed thoroughly. This pre-dilution 
was further diluted in in three steps to reach the exposure concentration of 0.01 µg Ag/
mL. 200 µL of the final dilution were added to each well. We used concentrations of 0.01 
µg/mL at which no change in metabolic toxicity has been shown in 16HBE14o-cells for 
NPs of the same type, from the same manufacturer and same sizes (20 and 50 nm) in 
absence of FCS in order to study uptake in uncompromised cells [41].
Cells and cell culture conditions
The human pulmonary epithelial cell line 16HBE14o (kindly provided by Dr. Gruenert, USA) 
was used in this study. 16HBE14o cells were cultured in Dulbecco’s Modified Eagle 
Medium/Nutrient Mixture F-12 + GlutaMAX (DMEM/F-12, Gibco, the Netherlands), 
supplemented with antibiotics (1% Penicillin-Streptomycin (Pen/Strep), Gibco, the 
Netherlands) and 5% Fetal calf serum (FCS, Gibco, the Netherlands) designated complete 
medium. When the cells reached an 80-100% confluent monolayer they were subcultured, 
usually 1:5 once a week in new 75 mL tissue culture flasks (CellStar®, Greiner Bio-one, the 
Netherlands). 16HBE14o-cells were harvested enzymatically using Trypsin solution 
(Trypsin-EDTA (0.05%), phenol red, Gibco, the Netherlands), counted, diluted and seeded 
into 96 well plates at cell densities of 60 000-65 000 cells/well 24 hours before exposure to 
allow them to rest and to reach 80-90% confluence the day of exposure. Cells were 
constantly incubated at 37°C and 5% CO2 atmosphere.
Cellular uptake of AgNPs
Cells were seeded in 96 well tissue culture plates as described in the “cell and cell culture 
conditions”-section and exposed to 200 µl of 0.01 µg/mL AgNP dispersions. The total 
Table 3.1   AgNP characteristics as provided by the manufacturer NanoComposix Inc
AgNP 
product 
[nm]
Average 
Diameter  
[nm]
Coefficient  
of variation 
[%]
SD [nm] Average 
Hydrodynamic 
diameter [nm]
Zeta 
Potential 
[mV]
Mass  
concentration  
[mg Ag/ml]
20 nm 19.6 8.1 1.6 24.0 -30.4 1.09
50 nm 53.5 8.3 4.4 56.0 -53.6 0.95
75 nm 74.8 5.8 4.3 78.5 -37.6 0.99
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exposure times were 0, 2, 4, 8, 12 and 24 hours. At the end of exposure, cells were 
thoroughly washed with Dulbecco’s Phosphate-Buffered Saline (DPBS, Without Calcium, 
Magnesium, Phenol Red, Gibco, the Netherlands) twice to remove loosely attached Ag 
ions and/or NPs from the cell membrane. 200 µL trypsin solution was added to detach the 
cells from the bottom of the well. Through pipetting it was made sure that all cells were 
detached, and successful detachment was confirmed by optical inspection with a light 
microscope (magnification 50x). Subsequently the sample was transferred to 15 mL 
polystyrene centrifuge tubes (Corning Life Sciences, the Netherlands) to be stored at 4°C 
until their measurement of tightly attached and internalized NPs. The samples were 
treated with 2 mL aqua regia (nitric acid, ultrapure and hydrochloric acid, ultrapure 1:3, 
both from Merck, Germany) and further diluted with ultra-pure water to a final volume of 
10 mL prior to the determination of the total Ag concentration (particle-associated as well 
as ionic Ag) by HR-ICP-MS type ELEMENT XR, ThermoFisher Scientific, Bremen, Germany. 
The sample introduction systems consisted of a concentric nebulizer, a cyclone spray 
chamber and nickel cones (all from the instrument supplier). For the quantification, 
external calibration with internal standard correction (Rhodium as 103Rh+) was applied. 
Sample pre-treatment and analysis were carried out in a cleanroom facility class 10 000. 
Each experiment was conducted independently two times for 50 and 75 nm AgNPs, and 
once for 20 nm AgNPs.
Statistical evaluation and calculations
For the determination of uptake rate constants c and elimination rate constants k, 
experimental results were evaluated with Microsoft Excel 2010 and the corresponding 
application “Solver” according to the one compartment model using Equation 3.1. Solver 
is a tool that determines the optimal value for variables, here c and k, within given limits in 
order to minimize differences between experimental and model data.
Equation 3.1
c(t) = c · (1 – e–kt)
k
Where t is the time of exposure in hours; c is the uptake rate constant in ng Ag·well-1·d-1; 
and k is the elimination rate constant in ng Ag·well-1·d-1. Values for k were set to a minimum 
of 10-8 in order to avoid divisions by zero during the calculations, no other limits are set. Ag 
concentrations were standardized to a starting concentration of zero by subtracting the 
initial concentration in the cells from the concentrations in the cells at the later time point.
To convert the amount of Ag/well as detected by HR-ICP-MS to assumed spherical NP 
numbers/well (NP No/well), the formulas according to [42] were used.
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Results
The original result of each sample point as well as the model uptake curves are given in 
Figure 3.1. Uptake did not clearly level off during the time course for all samples. For the 50 
and 75 nm samples without FCS the slope of the uptake curve clearly became less steep 
with time; the curve of the 75 nm samples with FCS levelled off slightly. In our set-up the 
uptake of 50 AgNPs was higher for medium without FCS than in medium supplemented 
with FCS, reaching approximately twice the maximum concentration after 24 hours of 
exposure. Uptake was also faster, as represented by the significantly different 95% 
confidence interval of the uptake rate constant c of 1.1·10-1-1.2·10-1 and 6.9·10-3-5.2·10-2 ng 
Ag·well-1·d-1 without and with FCS, respectively. For 20 nm and 75 nm AgNPs, the same 
trend was observed but not as pronounced, the difference in uptake rates is statistically 
not significant.
Figure 3.1  Ag amount in cells on mass basis with the fitted line for three NP sizes and medium 
without and with the addition of fetal calf serum based on one and two independent 
experiments for 20, and 50 and 75 nm particles, respectively. Note: Due to logistic aspects, 
the time points at which the samples have been obtained are slightly shifted sometimes 
(maximum 1 hour).
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No differences in uptake, expressed as ng Ag per well, for the three NP sizes could be 
observed in the presence of FCS (Table 3.2), their uptake rate constants were not significantly 
different. The mean of all three AgNP sizes fell within the same narrow range.
 Uptake in medium without FCS was faster and a size effect regarding the concentration 
at the latest time point could be seen (Figure 3.1, Figure S 3.1), although there is large 
variation between replicates. Uptake expressed as mass was highest for AgNPs with a size 
of 50 nm, reaching internal cell concentrations of approximately 65 % of the nominal 
concentration, followed by AgNPs of 75 nm and of 20 nm, each with roughly 50 % Ag 
uptake. For the latter AgNP size, only a single experiment was conducted, yet it did not fall 
into the confidence interval of the 50 nm samples. The uptake and elimination rates have 
been determined as presented in Table 3.2 and Table S 3.2, respectively. For medium 
supplemented with FCS, no difference in uptake rates could be detected (range: 0.03 to 
0.05 ng Ag·well-1·d-1). The observed trend of highest uptake for 50 nm AgNPs was not 
reflected in the uptake rate, as the confidence intervals overlap for 50 and 75 nm AgNPs.
A size optimum based on particle numbers does not necessarily lead to the same uptake 
optimum regarding NP mass [43]. To test whether this was the case here as well, the values 
were converted to particle numbers and their uptake rates compared. In this case, a clear 
difference, represented by the slope, was observed (Figure 3.2). The uptake rate, expressed 
as particle numbers per well per day, differed significantly for 20 nm AgNPs from the rate 
of 50 and 75 nm AgNPs, both in the absence and presence of FCS (Table 3.3). No difference 
in the uptake rate in presence of FCS could be observed for 50 and 75 nm AgNPs, while 
the rate was higher for 50 nm AgNPs than 75 nm AgNPs in the absence of FCS.
Table 3.2   Overview of the uptake curves based on mass [ng] Ag. Average uptake  
rate constants c, their standard deviation (Std. dev) and 95 % confidence Interval 
(CI) based on NP mass, all given in ng Ag·well-1·d-1.
NP size [nm], medium type c Std. dev. of c 95% CI of c
20 w/o FCS 4.2·10-2 n.a. n.a.
50 w/o FCS 1.1·10-1 4.0·10-3 1.1·10-1-1.2·10-1
75 w/o FCS 1.1·10-1 6.10·10-2 2.7·10-2-2.0·10-1
20+FCS 2.8·10-2 n.a. n.a.
50+FCS 2.9·10-2 1.6·10-2 6.9·10-3-5.2·10-2
75+FCS 4.8·10-2 2.9·10-2 7.5·10-3-8.8·10-2
n.a. not analyzed
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Figure 3.2  Average Ag content in cells on a NP number basis calculated from the 
independent mass based values for three NP sizes and medium without and with fetal calf 
serum as shown in figure 3.1. The two top graphs show model data for all three NP sizes 
for easy comparison and calculated average NP numbers for 20 nm AgNPs. The four 
graphs on the bottom show the average Ag content and the corresponding model data 
for 50 nm and 75 nm AgNPs in more detail. Note: Due to logistic aspects, the time points 
at which the samples have been obtained are slightly shifted sometimes (maximum 1 
hour); different scaling on the y-axes.
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Discussion
Our results show that the tissue culture medium composition in terms of presence or 
absence of fetal calf serum, effects NP uptake significantly, as confirmed by literature 
[34, 35, 40]. When no FCS is present final concentrations after 24 hours expressed on a 
mass basis are higher for 50 nm AgNPs than for 20 and 75 nm AgNPs. Internal cellular 
concentrations, expressed as a percentage of the nominal added concentrations, reached 
roughly 50% (20, 75 nm NPs) and 65 % (50 nm NPs). FCS decreases the amount of silver 
taken up on a mass basis by roughly 25 %, 54 % and 40 % for 20 nm, 50 nm and 75 nm 
AgNPs, respectively. A possible explanation is the formation of a protein corona around 
the AgNPs in the medium with FCS that reduces their uptake. Anionic bovine serum 
albumin for example showed repulsive interaction with the negatively charged cell 
membrane [44]. Recently it was reported that also for the uptake of fluorescent silica NPs 
an increase in serum concentration in the tissue culture medium resulted in a decrease in 
cellular uptake in human mesenchymal stem cells (hMSC) [45]. We show the importance 
to consider various medium compositions in toxicity studies, yet further confirmation for 
NPs of different charge and various types of serum proteins is needed. The higher uptake 
of 50 nm particles on mass basis in absence of FCS might be partially attributed to the 
more negative Zeta Potential of these AgNPs. At first, a higher uptake of more negatively 
charged NPs across the overall negatively charged cell membrane seems illogical due to 
repulsion. Yet, an early study already reports that positively charged patches on the cell 
surface exist [46]. The positively charged residues “seem to be accumulated in coated pits” 
[47]  and could, therefore, be responsible for the binding and uptake of negatively charged 
NPs. An increase in the absolute Zeta Potential usually leads to increased NP uptake in 
comparison with less charged NPs of the same size [23]. Whether size or charge has the 
greater influence on uptake remains unknown up to today due to a limited number of 
Table 3.3   Overview of the uptake curves based on NP numbers [NP No]. Average uptake 
rate constants c, their standard deviation (Std. dev) and 95 % confidence 
Interval (CI) based on NP number, all given in NP number·well-1·d-1.
NP size [nm], medium type C Std. dev. of c 95% CI of c
20 w/o FCS 1.0·106 n.a. n.a.
50 w/o FCS 1.4·105 4.7·103 1.3·105-1.4·105
75 w/o FCS 4.8·104 2.6·104 1.2·104-8.4·104
20+FCS 6.8·105 n.a. n.a.
50+FCS 3.5·104 1.9·104 8.2·103-6.1·104
75+FCS 2.1·104 1.3·104 3.2·103-3.8·104
n.a.: not analyzed
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uptake kinetics studies and a lack in availability of NPs with proper characteristics to study 
these phenomena. This stresses the need for commercially available NPs with only one 
property changed at a time or, ideally, that reference materials were made available.
 In contrast to the uptake studies by Chithrani et al. over 10 hours, uptake did not 
always clearly level off in time in our setup (Figure 3.1) [42]. This might be attributed to 
the different elemental NP composition (gold versus Ag) [48] and different cell lines 
(HeLa versus 16HBE14o) as summarized by us previously [23]; uptake of NPs also shows a 
concentration-dependency [30, 42, 49, 50]. Giljohann et al. showed that uptake does not 
necessarily relate to exposure concentrations in a linear fashion [45, 49]. Catalano et al. 
observed a levelling-off of the NP uptake in hMSC in the presence of serum whereas such 
a levelling-off was not present in the testing conditions without serum over a time course 
of only 6 hours, what makes a comparison with our results difficult [45]. Yet, our results 
show the opposite trend also for such short incubation times. Overall, our results show 
that uptake kinetics differ per NP and should be taken into account in toxicity studies.
 Although generally mass is used as dosing parameter (it is also highly practical and 
convenient) for nanoparticles the unit that reacts with a cell is the whole particle. When 
mass is used as a dose for a soluble chemical this translates to a number of molecules 
reacting with a cell or cell receptors. Although nanoparticles also are composed of 
molecules and these molecules can react with cell receptors, due to its form (e.g. spherical, 
cube or tube-like) not all individual molecules can react with a cell or cell receptor. It is the 
whole particle that can be composed of a few but also many molecules depending on 
the size (and size distribution) of the investigated nanoparticle.  So, a dose in mass, for 
nanoparticles, cannot be translated in a dose of molecules interacting with a cell or cell 
receptor. The dose in nanotoxicology is still under debate and can be dependent on the 
toxic parameter investigated. For example for lung inflammation the total surface area 
was found to be a better dose description than mass [14]. Also, it is debated whether for 
in vitro cytotoxicity experiments the dose in the medium should be used (in concentration 
of mass, surface area or particle number) or the dose as what the cells see or take up [51, 52]. 
 It is also clearly shown that the measurand, in which results are presented, plays a very 
important role in the interpretation of the results. While in most cases no significant 
difference in uptake rate can be detected on a mass basis, there is a very clear effect of 
particle size on the uptake rate of 20 nm AgNPs when the results are presented on a 
number of particle basis (Figure 3.2). Uptake of smaller particles is faster than of larger 
particles independent of the culture medium composition, except for 50 and 75 nm 
AgNPs+ FCS where no significant difference was observed, but the total mass is equally 
fast, except for 20 and 50 nm AgNPs w/o FCS. The size optimum, which relates to the 
highest uptake rate, of 50 nm is only in good agreement with other studies when 
expressed on a mass basis, while it is not when expressed as particle number [39, 42]. In 
contrast to us, those studies found the highest uptake rate at 50 nm based on a particle 
number basis in various cell lines. Few other studies exist where uptake rates have been 
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determined, yet they are difficult to compare to our studies. The reasons for this is the 
difference in the used NP sizes. The following results are all converted to and reported on 
NP number basis. Uptake rates are found to be highest for 44 nm, followed by 114 nm and 
33 nm [53]. The other researchers find 32 nm to show highest uptake rates, followed by 
70 nm, 102 nm, and 118 nm respectively [38]. They originally report their results on mass 
basis, then the order is as follows: 102 nm, 70 nm, 118 nm, 32 nm. No clear pattern can be 
observed on mass basis. Only one of the few studies that also determine uptake rates is 
in agreement with our results.  Expressed on NP number basis, uptake rates are also highest 
for 20 nm particles, followed by 40 nm and lowest for 100 nm [54]. Therefore, no 
conclusions about uptake optima based on particle number basis can be directly drawn 
even though all studied cell lines can utilize the mechanism of endocytosis just as 16HBE 
cells. The exact uptake mechanism for AgNPs into 16HBE cells used in our experiments is 
unknown because the determination of the exact uptake mechanism is very complex. 
It requires the determination of the exact concentration and incubation time for various 
inhibitors and has to be adjusted for each cell line separately [55]. Pinocytosis  can be 
excluded as the uptake mechanism because it is a non-saturable process and saturation 
is clearly observed [56]. 
 The non-uniform way of presenting results may lead to misinterpretation and false 
conclusions about agreement between studies, as criticized by [43]. They showed that an 
optimum based on the number of particles per cell does not necessarily lead to the same 
optimum in terms of mass. This was also nicely shown by Yue et al., who graphically showed 
that the size optimum depends on the measurand (number of particles per cell, particle 
volume per cell, and particle surface area per cell) [57].
 We therefore recommend to pay close attention to the measurand given in various 
studies and would find it helpful if the optimum was given also in different measurands in 
one study for comparability between studies. Often important data for such conversions 
are not directly accessible in publications, e.g. it might be difficult to calculate the number 
of atoms per particle because only the total diameter is known but not the thickness of 
a coating.
Conclusion
The present study shows that the medium composition (absence or presence of FCS), 
has a large effect on the speed of uptake and therefore the maximum concentration 
after 24 hours of exposure. This should be taken into consideration in (toxicity-) studies, 
where uptake and internal concentration play a crucial role in understanding the mechanism 
of the observed effects. Uptake in medium without FCS shows a trend towards higher 
uptake for 50 nm AgNPs than 75 and 20 nm AgNPs on a mass basis. This uptake optimum 
shifts to 20 nm AgNPs when expressed on AgNP number basis in contrast to other results 
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reported in literature. For comparability between studies, direct conversion of uptake 
expressed as NP number and mass in one publication is advantageous; sometimes the 
necessary information to do so oneself is not directly available in the publication. Future 
developments will greatly benefit from the use of reference materials. Since the large and 
continuously growing number of engineered NPs cannot all be covered experimentally, 
comparability between studies would possibly help to close knowledge gaps and allow 
for extrapolation regarding uptake between different NPs by modelling. Modelling will be 
an indispensable tool to cover the large and continuously growing number of engineered 
NPs and to predict the uptake of untested NPs.
Supplementary material
Figure S 3.1 Ag amount on bass basis with 95% confidence intervals; Table S 3.2 Overview 
of the elimination rates based on mass [ng] Ag; Table S 3.3 Overview of the elimination rates 
based on NP numbers [NP No].
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Appendix
Figure S 3.1  Ag amount on bass basis with 95% confidence intervals.
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Table S 3.1   Overview of the elimination rates based on mass [ng] Ag.  
Average elimination rate constants k, their standard deviation (Std. dev) and 
95 % confidence Interval (CI) based on NP mass, all given in ng Ag·well-1·d-1.
NP size [nm], medium type k Std. dev. of k 95% CI of k
20 w/o FCS 1.0·10-7 n.a. n.a.
50 w/o FCS 7.3·10-2 5.3·10-3 6.5·10-2-8.0·10-2
75 w/o FCS 9.9·10-2 8.9·10-2 -2.4·10-2-2.2·10-1
20+FCS 1.9·10-3 n.a. n.a.
50+FCS 1.1·10-2 1.6·10-2 -1.1·10-2-3.3·10-2
75+FCS 4.9·10-2 6.2·10-2 -3.6·10-2-1.3·10-1
n.a.: not analyzed
Table S 3.2   Overview of the elimination rates based on NP numbers [NP No].  
Average elimination rate constants k, their standard deviation (Std. dev) and 
95 % confidence Interval (CI) based on NP number, all given in  
NP number·well-1·d-1.
NP size [nm], medium type k Std. dev. of k 95 % CI of k
20 w/o FCS 1·10-8 n.a. n.a.
50 w/o FCS 7.3·10-2 5.3·10-3 6.5·10-2-8.0·10-2
75 w/o FCS 1.0·10-1 8.9·10-2 -2.4·10-2-2.2·10-1
20+FCS 1.9·10-3 n.a. n.a.
50+FCS 1.1·10-2 1.6·10-2 -1.1·10-2-3.3·10-2
75+FCS 4.9·10-2 6.2·10-2 -3.6·10-2-1.4·10-1
n.a.: not analyzed
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Abstract
Human health risks by silver nanoparticle (AgNP) exposure are likely to increase due to the 
increasing number of NP containing products and demonstrated adverse effects in 
various cell lines. Unfortunately, results from (toxicity-) studies are often based on exposure 
dose and are often measured only at a fixed time point. NP uptake kinetics and the 
time-dependent internal cellular concentration are often not considered. Macrophages 
are the first line of defense against invading foreign agents including NPs. How 
macrophages deal with the particles is essential for potential toxicity of the NPs. However, 
there is a considerable lack of uptake studies of particles in the nanometer range and 
macrophage-like cells. Therefore, uptake rates were determined over 24 hours for three 
different AgNPs sizes (20, 50 and 75 nm) in medium with and without fetal calf serum. 
Non-toxic concentrations of 10 ng Ag/mL for monocytic THP-1 cells, representing realistic 
exposure concentration for short term exposures, were chosen. The uptake of Ag was 
higher in medium without fetal calf serum and showed increasing uptake for decreasing 
NP sizes, both on NP mass and number basis. Internal cellular concentrations reached 
roughly 32%/ 10%, 25%/ 18%, and 21%/ 15% of the nominal concentration in absence of 
fetal calf serum/with fetal calf serum for 20, 50 and 75 nm NPs, respectively. Our research 
shows that uptake kinetics in macrophages differ for various NP sizes. To increase the 
understanding of the mechanism of NP toxicity in cells, the process of uptake (timing) 
should be considered.
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Introduction
Nanoparticles (NPs) have dimensions from 1 nm up to 100 nm by common consensus [1]. 
Their unique physical and chemical properties arouse high interest by industry regarding 
their use for consumer products and medical applications as previously described in more 
detail [2]. The same properties that make them interesting for industrial applications, 
especially their small size and high reactivity, raise serious concerns regarding a potential 
risk to human health and biota on the long term [3] through exposure via one of the four 
exposure routes: injection, dermal and intestinal uptake, and inhalation; the latest being 
considered the most important especially during NP production and processing [4]. 
Exposure to NPs and subsequent uptake has been shown to affect various cell lines, 
including phagocytosing cells like THP-1-derived macrophages [5-8]. Unfortunately, 
uptake kinetics and time-dependent internal cellular concentrations are often neglected 
in experiments with measurements after a single fixed point in time and toxicity is related 
to exposure dose instead. Uptake is known to be influenced by NP properties such as size, 
as shown for various cell lines in vitro. Unfortunately, uptake has only been detected after 
a fixed time point in many studies [9-13].
 Uptake of NPs into cells, after contact via one of the four exposure routes, occurs 
through two fundamental biological processes namely pinocytosis and phagocytosis, 
both tailor fit for their biological function. These fundamental biological mechanisms are 
responsible for the uptake of molecules from the environment. NPs have been shown to 
be able to enter cells via these two mechanisms as summarized by [14]. Pinocytosis, a 
mechanism usually employed by eukaryotic cells, such as 16HBE14o cells, to take up small 
essential nutrients [15], is described in more details elsewhere [2]. The vesicles reach sizes 
of up to 80 nm in diameter (i.d.) for caveolae-mediated endocytosis or 120 nm i.d. for 
clathrin-mediated endocytosis. Phagocytosis on the other hand is a more specialized 
mechanism that can be found in unicellular organisms as well as in complex multicellular 
animals [16, 17]. Phagocytosis as part of the immune defense in animals, is special in the 
way that it is restricted to a few types of cells, such as monocytes, neutrophils, and 
macrophages, to which THP-1 cells belong. Phagocytosis is a ligand-induced process, so 
especially the presence or absence of serum proteins have great effects on NP uptake as 
summarized previously [14]; the formed vesicles reach sizes between 0.5 µm to 10 µm [18]. 
In presence of proteins a so called protein corona on the NPs surface may be formed, 
leading to uptake that can be increased, decreased or remain the same, depending on the 
surface composition of the NPs, the type of cell and proteins and/or other biomolecules 
present on the NP surface [19-21].
 Very few efforts have been made to study the size-dependent uptake of NPs with 
diameters smaller than 100 nm into phagocytising cells. Uptake rates over time where 
determined in two studies only [22, 23], while the majority only reports uptake at one 
single point in time [11, 24-26]. In addition, these studies are also inconclusive about the 
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effect of size on uptake into phagocytising cells. To overcome this lack in data, we 
determine uptake rates for different AgNPs sizes in cell culture medium with and without 
FCS in this study. Previously it was shown that similar AgNPs induced cellular toxicity for 
the murine macrophage cell line RAW264.7 at concentrations of approximately 10 µg/mL 
and higher [8]. In this study low nontoxic concentrations of 0.01 µg/mL were used to study 
cell uptake without inducing toxicity. Cells were, therefore, exposed to NPs for different 
periods of time over 24 hours under realistic concentrations for short term exposures. 
These data will deliver new insights into the effect of NP size on their uptake rate and are 
required to model and predict NP uptake rates based on easily measurable NP properties. 
The number of applications and produced quantities of NPs are increasing [27-29] and 
especially the combination of empirical data like ours and modelling will allow for time- 
and cost-effective risk assessment of the ever increasing number of NPs.
Material and Methods
A detailed description of the material and methods can be found elsewhere [2], so here 
only a brief description is given.
Nanoparticles
Keeping the  possible vesicles size of up to 80 nm in diameter (i.d.) for caveolae-mediated 
endocytosis in mind and to avoid an overlap in the size distribution of NPs, we chose NPs 
with diameter of 20, 50 and 75 nm. The following AgNPs were purchased from 
NanoComposix Inc (San Diego, CA): 20 nm Citrate BioPure™ Silver, 50 nm Citrate BioPure™ 
Silver and 75 nm Citrate BioPure™ Silver. The supplier provided detailed information about 
the NPs characteristics [2].
Preparation of AgNPs dispersions
Due to the significant effects serum proteins present in cell culture growth medium may 
have on uptake, these uptake studies were conducted with media with fetal calf serum 
(+FCS) and without (w/o) [19-21]. The dilutions of AgNPs dispersions were performed in 
complete cell culture medium (see below), either without or with FCS, prior to exposure. 
Final exposure concentrations of 0.01 µg Ag/mL were obtained in several steps of 
pre-dilutions. We used very low concentrations of 0.01 µg/mL at which we do not expect 
cellular cytotoxicity. Similar AgNPs (20 nm and 80 nm) of the same supplier induced 
cellular toxicity for the murine macrophage cell line RAW264.7 at concentrations of 
approximately 10 µg/mL and higher (Park et al., 2011). Also for .THP-1-cells at low 
concentrations no cytotoxicity was noted for similar (20 and 50 nm) AgNPs of the same 
manufacturer (H.M. Braakhuis, personal communication). In addition, these concentrations 
represent realistic concentrations for short term occupational alveolar lung exposures [30]. 
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Cells and cell culture conditions
The human monocytic cell line (THP-1, ATCC) was used in this study. THP-1 cells were 
cultured in Roswell Park Memorial Institute (RPMI) 1640 cell culture growth medium, 
supplemented with 10% Fetal calf serum, and antibiotics (1% Penicillin-Streptomycin (Pen/
Strep), all obtained from Gibco, The Netherlands). This is designated complete medium. 
Cells were subcultured usually twice a week not to exceed a concentration of 1·106 viable 
cells/mL. Subcultures where started with a cell density of 2·105 to 4·105 viable cells/mL. 
Cells were constantly incubated at 37°C and 5% CO2 atmosphere. Seven days prior to 
exposure to AgNPs, THP-1 were differentiated to macrophages according to the following 
procedure: THP-1 were diluted to a concentration of 5·105 viable cells/mL to which phorbol 
myristate acetate (PMA, Sigma, The Netherlands) was added to reach a final concentration 
of 30 ng PMA/mL. Afterwards, 1·105 viable cells were added per well of a 96 flat button cell 
culture plate to differentiate and become adherent. On day 5, medium was replaced by 
fresh medium; on day 7 the cells were exposed to AgNPs as described in section ‘cellular 
uptake of AgNPs’.
Cellular uptake of AgNPs
Cells were seeded in 96 well cell culture plates as described in the “cell and cell culture 
conditions”-section and exposed to 200 µl of 0.01 µg/mL AgNP dispersions. The total 
exposure times were 0, 2, 4, 8, 12 and 24 hours. Note: Due to logistic aspects, the time 
points at which the samples have been obtained are slightly shifted sometimes (maximum 
2 hours). At the end of exposure, cells were thoroughly washed with Dulbecco’s Phosphate- 
Buffered Saline (DPBS, Without Calcium, Magnesium, Phenol Red, Gibco, the Netherlands) 
twice to remove loosely attached Ag ions and/or NPs from the cell membrane. 200 µL 
trypsin solution (Gibco, The Netherlands) was added to detach the cells from the bottom 
of the well. Through pipetting it was made sure that all cells were detached, and successful 
detachment was confirmed by optical inspection with a light microscope (magnification 
50x). Each experiment was conducted independently two times for 20 nm AgNPs, and 
three times for 50 and 75 nm AgNPs.
Statistical evaluation and calculations
For the determination of uptake rate constants c and elimination rate constants k, 
experimental results were evaluated with Microsoft Excel 2010 and the corresponding 
application “Solver” according to the one compartment model using Equation 4.1. 
Solver is a tool that determines the optimal value for variables, here c and k, within given 
limits in order to minimize differences between experimental and model data.
Equation 4.1
c(t) = c · (1 – e–kt)
k
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Where t is the time of exposure in hours; c is the uptake rate constant in ng Ag·well-1·day-1; 
and k is the elimination rate constant in ng Ag·well-1·day-1. Values for k were set to a 
minimum of 10-8 in order to avoid divisions by zero during the calculations, no other limits 
are set. Ag concentrations were standardized to a starting concentration of zero by 
subtracting the initial concentration in the cells from the concentrations in the cells at 
the later time point.
Results
The results for each replicate, as well as the according model uptake curves, for the three 
NP sizes are given in Figure 4.1. The data points displayed in light grey belonging to data 
set 3 of the 50 nm samples w/o and +FCS were evaluated as outliers, likely due to insufficient 
washing, and were not considered in the calculations for the model curve. Uptake clearly 
levelled off during the time course for all samples except for the 50 nm +FCS where the 
rate of uptake stayed constant over 24 hours. In our set-up, the average uptake in absence 
of FCS was higher than in the presence of FCS for 20 and 50 nm particles, reaching highest 
intra cellular concentrations after 24 hours. This effect was most pronounced for 20 nm 
particles reaching an approximately three fold higher maximum concentration after 
24 hours of exposure in the absence of FCS than in presence of it. Average internal cellular 
concentrations after 24 hours decreased with increasing particle size in absence of FCS, 
reaching approximately 32%, 25% and 21% of the nominal concentration for 20, 50 and 
75 nm particles, respectively.
The uptake and elimination rates on mass basis are given in Table 4.1 and Table S 4.1. The uptake 
rate constants are significantly different between media composition for 20 and 50 nm 
particles. In absence of FCS, uptake was also faster for the smallest particles compared to 
50 nm particles as represented by the significantly different 95% confidence interval of the 
uptake rate constant c. No significant difference in uptake rate was found between the 
other NP sizes due to the large difference in uptake rates between replicates of 75 nm 
particles.
The measurand in which results are presented (mass versus number of NP) is crucial 
because a size optimum based on mass does not necessarily lead to the same uptake 
optimum regarding NP numbers [31]. In our case, where uptake on mass basis is highest 
for the smallest NP size, the same will hold true on NP basis. Yet, when expressed on NP 
number basis, the difference might become significant. To test whether this is the case, 
and for comparison with other studies, NP numbers were calculated. The results without 
FCS change in so far, that the uptake rate of 20 nm AgNPs differs significantly from those 
of 50 nm and 75 nm AgNPs. 
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Figure 4.1  Ag amount in cells on mass basis with the fitted line for three NP sizes and 
medium without and with fetal calf serum based on at least two independent experiments 
(data 1 to data 3). The light gray data points belonging to data set 3 are indicated as outliers 
and were not considered in the determination of the fitted line. Note Due to logistic 
aspects, the time points at which the samples have been obtained are slightly shifted 
sometimes.
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Table 4.1   Overview of the uptake rates based on mass [ng] Ag
NP size [nm], medium type c Std. dev. of c 95% CI of c
20 w/o FCS 1.0·10-1 1.5·10-2 8.0·10-2-1.2·10-1
50 w/o FCS 5.6·10-2 2.0·10-2 3.3·10-2-7.8·10-2
75 w/o FCS 1.4·10-1 1.2·10-1 9.5·10-3-2.7·10-1
20+FCS 2.1·10-2 1.1·10-3 1.9·10-2-2.3·10-2
50+FCS 2.2·10-2 5.8·10-3 1.6·10-2-2.9·10-2
75+FCS 5.6·10-2 3.5·10-2 1.6·10-2-9.6·10-2
Average uptake rate constants c and elimination rate constants k, their standard deviation (Std. dev) and 95 % 
confidence Interval (CI) based on mass, all given in ng Ag·well-1·day-1.
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The uptake rates are not significantly different for 50 and 75 nm AgNPs in absence of FCS. 
THP-1 cells favor the uptake of smaller AgNPs on NP number basis in absence of FCS. 
This is depicted in Figure 4.2.
Discussion
Our results show that the cell culture medium composition in terms of presence or 
absence of FCS, affected the AgNP uptake in the macrophages considerably for 20 nm 
AgNPs (3 times higher uptake) and 50 nm AgNPs, as confirmed by literature [19-21]. In 
medium with FCS, a so called “protein corona” around the AgNPs might be formed 
reducing uptake. 
Figure 4.2  Average Ag content in cells on a NP number basis calculated from the independent 
mass based values for three NP sizes and medium without and with fetal calf serum as 
shown in Figure 4.1. The two top graphs show model data for all three NP sizes for easy 
comparison and calculated average NP numbers for 20 nm AgNPs. The four graphs on the 
bottom show the average Ag content and the corresponding model data for 50 nm and 75 
nm AgnPs in more detail. Note Due to logistic aspects, the time points at which the samples 
have been obtained are slightly shifted sometimes; different scaling on the y-axes.
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The protein corona can lead to repulsive interaction with the negatively charged cell 
membrane as shown for anionic bovine serum albumin [32]. Yet, further confirmation for 
NPs of different charge and various types of serum proteins and other biomolecules that 
might be part of the protein corona is needed. When no FCS was present, final concentrations 
after 24 hours were found to be higher for the smaller NPs. Uptake changes over time and 
levels off after approximately 12 hours. Overall, our results show that uptake kinetics may 
differ per NP and therefore should be taken into account in toxicity studies (Table 4.2).
After inhalation lung macrophages are the most important cells for removal of the inhaled 
NPs from the lung. However, studies determining uptake by phagocytosing cells for 
particles in the nano-range and considering uptake over time are scarce and up to now 
inconclusive. Our results show that the amount taken up was in the order 20>50=75 nm 
without FCS, and 50=75>20 nm in the presence of FCS on mass basis. In contrast to our 
findings that uptake is highest for smallest NPs, uptake by macrophages based on mass is 
less effective for smaller PEGylated NPs than their larger counterparts [22]. Uptake 
efficiency increases from 30 nm NPs, over 40 nm NPs, to 100 nm NPs. HeLa cells on the 
other hand favor the intermediate size with uptake in the following order: 50>30>74>14>100 
on NP number basis [23]. It would be interesting to see whether and how these trends 
changes when expressed on mass basis.
 We therefore recommend that the optimum uptake is presented in both measurands 
to allow for comparability between studies. Alternatively, data that allow for such 
conversions might be given. Such a conversion is difficult if, e.g. the total diameter is 
known but not the thickness of a coating. Levy et al. also showed that an optimum based 
on the number of NPs per cell does not necessarily lead to the same optimum in terms of 
mass [31]. Yue et al. graphically visualized the dependence of the size optimum on the 
measurand (number of particles per cell, particle volume per cell, and particle surface area 
per cell) [33].
Table 4.2   Overview of the uptake rates based on AgNP numbers
NP size [nm], medium type c Std. dev. of c 95% CI of c
20 w/o FCS 1.2·1010 1.6·109 1.0·1010-1.5·1010
50 w/o FCS 4.5·108 1.1·108 3.4·108-5.7·108
75 w/o FCS 3.1·108 2.6·108 1.8·107-6.0·108
20+FCS 2.5·109 1.4·108 2.3·109-2.7·109
50+FCS 1.3·108 3.4·107 9.5·107-1.7·108
75+FCS 1.2·108 8.0·107 3.3·107-2.1·108
Average uptake rate constants c and elimination rate constants k, their standard deviation (Std. dev) and 95 % 
confidence Interval (CI) based on AgNP numbers, all given in AgNPs·well-1·day-1.
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Different trends in the optimal particle size for uptake can be attributed to the numerous 
experimental factors that differ between studies, for example different NP materials and 
the use of FCS during incubation and whether opsonisation takes place, as summarized 
previously by us [14]. Surface charge also effects NP uptake, an increase in the absolute Zeta 
Potential usually leads to increased NP uptake in comparison with less charged NPs [14]. 
For the 50 nm AgNPs used in this study, charge might to some extend also determine uptake 
in comparison to the other AgNPs because their Zeta Potential differs from that of the 20 
and 75 nm AgNPs from the same manufacturer. This stresses the need for commercially 
available NPs with only one property changed at a time or, ideally, that reference materials 
we made available.
 Other factors that influence uptake are the use of various cell lines, different possible 
uptake mechanisms, and exposure concentration. While phagocytosis is usually considered to 
take place for materials with sizes larger than 0.5 µm, Kuhn et al. showed that polystyrene 
NPs with sizes of 28 nm were taken up by J774A.1 macrophages via micropinocytosis and 
phagocytosis, as well as clathrin-mediated endocytosis [34]. The exact uptake mechanism 
for AgNPs into THP-1 cells used in our experiments is unknown. The uptake mechanism 
can vary between differentiated and undifferentiated THP-1 cells [35]. In addition, the 
determination of the exact concentration and incubation time for the various inhibitors 
is very complex and have to be adjusted for each cell line separately [34]. Saturation of 
uptake is observed, therefore pinocytosis, a non-saturable process, as the uptake mechanism 
can be excluded [36].
Conclusions
Our study clearly shows that the presence of FCS reduces cellular uptake for AgNPs of 
different sizes in the macrophage cell line THP-1 and that uptake should be reported both 
as NP number and mass based uptake. Our results show that reporting both in every 
study is important as the order of uptake in relation to NP size might change with the 
measurand and would be advantageous for easy comparison of results. Studies that 
determine uptake kinetics of particles with sizes below 100 nm by phagocytosing cells are 
scarce, stressing the need for further experimental investigation similar to the presented 
work. Therefore, patterns for the effect of particle size on uptake rate into phagocytosing 
cells are uncertain. Future developments will benefit most from studies where either the 
same NPs are tested in various phagocytosing cell lines known for their different endocytic 
uptake mechanisms (e.g. clathrin- versus caveolae-mediated endocytosis) or NPs of different 
chemical composition that are tested in the same cell line in order to fill knowledge gaps 
and resolve apparent contradictions. Once patterns emerge, extrapolation between 
different NPs and between different experimental conditions will be possible. Modelling 
will be an indispensable tool to cover the large and continuously growing number of 
engineered NPs and to predict the uptake of untested NPs.
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Supplementary material
Table S 4.1 Overview of the elimination rates based on mass [ng] Ag. Table S 4.2 Overview 
of the elimination rates based on AgNP numbers.
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Appendix
Table S 4.1   Overview of the elimination rates based on mass [ng] Ag.
NP size [nm], medium type k Std. dev. of k 95% CI of k
20 w/o FCS 1.6·10-1 5.3·10-2 8.3·10-2-2.3·10-1
50 w/o FCS 9.4·10-2 8.5·10-2 -1.9·10-3-1.9·10-1
75 w/o FCS 3.2·10-1 2.4·10-1 4.8·10-2-5.9·10-1
20+FCS 1.0·10-1 1.9·10-2 7.3·10-2-1.3·10-1
50+FCS 4.2·10-2 4.7·10-2 -1.2·10-2-9.5·10-2
75+FCS 1.7·10-1 1.3·10-1 2.7·10-2-3.2·10-1
Average elimination rate constants k, their standard deviation (Std. dev) and 95 % confidence Interval (CI) based 
on mass, all given in ng Ag·well-1·day-1.
Table S 4.2   Overview of the uptake and elimination rates based on AgNP numbers.
NP size [nm], medium type k Std. dev. of k 95% CI of k
20 w/o FCS 1.4·10-1 4.3·10-2 8.4·10-2-2.0·10-1
50 w/o FCS 8.6·10-2 7.6·10-2 4.2·10-4-1.7·10-1
75 w/o FCS 3.0·10-1 2.3·10-1 3.44·10-2-5.6·10-1
20+FCS 9.1·10-2 1.5·10-2 7.0·10-2-1.1·10-1
50+FCS 3.7·10-2 4.1·10-2 -9.3·10-3-8.4·10-2
75+FCS 1.6·10-1 1.2·10-1 2.3·10-2-3.0·10-1
Average elimination rate constants k, their standard deviation (Std. dev) and 95 % confidence Interval (CI) based 
on AgNP numbers, all given in AgNPs·well-1·day-1.
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Abstract
The evaluation of the uptake of nanomaterials by cells in vitro tests is of great relevance to 
understand potential toxicity mechanisms of nanomaterials. As an example, the uptake of 
medium-sized nanosilver (size range of 50 and 75 nm) was studied closely for a relevant 
human lung cell line (THP-1). Time dependent uptake was studied in relation to different 
cell culture media with or without the addition of fetal calf serum (FCS). After cell isolation, 
washing, acid digestion and quantification of silver (Ag) by inductively coupled plasma 
mass spectrometry (ICPMS) were applied to study the general uptake. It is demonstrated 
that the uptake of Ag (from 75 nm Ag nanoparticles) is a factor of 5 higher in a medium 
without FCS in comparison to the medium with FCS. In addition, the stability and the 
abundance of Ag nanoparticles in the supernatant after cell exposure were studied in 
relation to different timings. By means of asymmetric flow field flow fractionation (AF4) for 
the size dependent particle separation and an on-line hyphenation to the sensitive 
elemental detection by ICPMS, different Ag particles were separated and further identified. 
By combining results from the total uptake of Ag by cells with results obtained from the 
analysis of the supernatant, total recoveries of 98 to 104% were determined in relation to 
the exposed concentration of Ag. Finally, the influence of the medium composition (with 
or without FCS) on the stability of 50 nm Ag nanoparticles was studied directly after 
spiking. A method by AF4-ICPMS was applied and the obtained fractograms confirm a 
clear influence of the different composed media composition and particle size on cellular 
uptake. The developed and applied ICPMS methods were found to be suitable approaches 
to evaluate the potential uptake of inorganic nanoparticles by cells.
Keywords
Silver nanoparticles, cell medium, macrophages THP-1 cell line, asymmetric flow field flow 
fractionation, inductively coupled plasma mass spectrometry 
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Introduction
Engineered nanomaterials (ENMs) and nanoparticles (ENPs) are used in a rapidly increasing 
number of modern products. It is crucial to understand and effectively manage potential 
human health and environmental risks of these materials [1-5]. Human exposure may 
occur via the release of ENMs and ENPs from the material during the use of consumer 
products and/or indirectly at the end of the product life cycle and possible release in the 
environment.
 Silver (Ag) and Ag ENPs have an inherent antimicrobial activity which has led to their 
use in consumer products such as spray application with disinfectants, deodorants, 
antimicrobial sprays and powders [6]. Exposure to nanosilver can occur through ingestion 
or dermal contact but inhalation is considered as the most relevant route of exposure for 
potential hazardous effects [7, 8]. The capacity of ENPs to pass (or not) barriers and 
subsequently become systemically bioavailable is of great interest. Various parameters, 
like particle size/size distribution, shape, elemental composition, agglomeration/ 
aggregation state, surface composition, purity, surface area, surface chemistry and surface 
charge, must be taken into account [5]. In vivo inhalation studies with nanosilver show 
diverse outcomes up to now. Some studies showed no induction of adverse effects [9, 10], 
while other studies reported adverse effects varying from a minimal inflammatory 
response to the presence of inflammatory lesions in the lungs [11].
 In vitro experiments represent a relevant and fast approach to screen ENPs on their 
cytotoxicity, inflammation, genotoxicity and develop- mental toxicity [12] and in vitro 
assays may also be used to mimic inhalatory routes of exposure by a so-called air liquid 
interface model. The solubility under physiological conditions and translocation of ENPs 
can be studied by systematic variations of experimental conditions. A large range of 
human cell lines is available for in vitro testing. Human liver cells like HepG2 and colon 
Caco2 cells are well studied cell lines in relation to nanosilver [13, 14]. As ENPs tend to end 
up in phagocytizing cells, a human acute monocytic leukemia cell line (THP-1) can be 
used for exposure testing. Since their establishment thirty years ago, THP-1 cells have 
become one of most widely used cell lines to investigate the function and regulation of 
monocytes and macrophages in the cardiovascular system [15]. So far, there are no 
detailed studies published about the exposure and the uptake of Ag ENPs by THP-1 cells.
 It is crucial for the interpretation of in vitro uptake studies that sufficient information 
on the particle stability of the chosen ENPs under the given experimental circumstances 
is available. The concept of primary particle size must be confirmed under the given 
experimental conditions. The development of new methods for the analytical characteri-
zation of ENPs in complex matrices will be extended to guarantee sufficient reliability of 
the analytical results. From an analytical point of view, inductively coupled plasma mass 
spectrometry (ICPMS) offers an ideal platform to study possible effects.
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An analytical tool platform needs to be established to obtain more details about the Ag 
ENPs stability in in vitro experiments with cells lines. After cell isolation, washing and acid 
dissolution, the total content of Ag taken up by cells is determined by ICPMS. Determination 
in hyphenation to on-line size dependent particle separation by asymmetric flow 
field flow fractionation (AF4) represents a new challenge. Recently, methods for the 
identification and quantification of ENPs were developed. Asymmetric flow field flow 
fractionation (AF4)-inductively coupled plasma mass spectrometry (ICPMS) is applied for 
quantification of metallic ENPs [16-18]. Commonly, Ag ENPs in less complex matrices like 
aqueous matrices can be separated by AF4 [19, 20]. To the best of our knowledge, only one 
publication is dealing about the analytical method of nanosilver in relation to cell line; 
in this case smaller (15 nm) ENPs and Ag(I) were studied with HepG2 cells by AF4-ICPMS [14].
 Within this study, three experimental scenarios with medium-sized (range 50 and 75 
nm) Ag ENPs are investigated in relation to human lung cells (THP-1) and variable tissue 
culture media compositions in which the presence or absence of the most widely used 
serum- supplement fetal calf serum (FCS) is of great importance.
Material and methods
Chemicals
Two sizes of Ag NPs were used for studying their stability in different Complex in vitro media:
1. Ag nanospheres of 75 nm with citrate capping agent: 1 mg/mL Ag;
2. Ag nanospheres of 50 nm with citrate capping agent: 1 mg/mL Ag.
For the identification of derivatives, also Ag nanospheres of 20 nm with citrate capping 
agent: 1 mg/mL Ag, were used.
The related particle sizes refer to the specification sheets provided by the manufacturer. 
All NPs were from the product line BioPure and supplied by NanoComposix, San Diego, 
USA. In addition, the suspensions of NPs were stored and handled according to the 
supplier’s instructions which were given on the related specification sheets.
 Ultrapure water (H2O) with a resistivity of > 18 M Ω cm was obtained from a Milli-Q 
Plus system (Millipore, Amsterdam, the Netherlands). Hydrochloric acid (HCl), 30%, ultrapur 
and nitric acid (HNO3), 65%, ultrapur, were purchased from Merck, Darmstadt, Germany. 
Sodiumdodecylsulfate (SDS), > 99%, was purchased from Sigma Aldrich, Zwijndrecht, 
the Netherlands. The calibration standard solution of Ag and the internal standard related 
to the ICPMS measurement (chosen element: rhodium (Rh)) were made of single element 
stock solutions with a concentration of 1 mg/mL from Inorganic Ventures, Christiansburg, 
USA.
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Cell line and media
The human macrophage THP-1 cell line was obtained from ATCC (LGC Standards, Wesel, 
Germany). The cells were seeded in CELLSTAR® 96 well plates, supplied by Greiner Bio-One B.V., 
Alphen a/d Rijn, The Netherlands, at a density of 100,000 cells/well. RPMI 1640 medium 
supplemented with 10 vol. % fetal calf serum (FCS; Gibco 16010-159), 1 vol. % penicillin–
streptomycin solution (10,000 U/mL/10,000 lg/mL, Gibco 15040) was used. The medium RPMI 
1640 is composed of 42 components; the detailed composition is given on [21]. All cell 
media were supplied by Life Technologies Europe BV, Bleiswijk, The Netherlands. Phorbol 
myristate acetate (PMA; from Sigma Aldrich, Zwijndrecht, The Netherlands) was added to the 
medium with a final concentration of 30 ng/mL in order to stimulate differentiation from 
the monocytic phenotype to macrophages until day five. The medium was refreshed and the 
cells were left to rest for two more days. The cells were constantly grown at 37 °C with 5% CO2.
Instrumentation
For the total quantification of Ag in cell pellets, a high resolution (HR)-ICPMS type ELEMENT 
XR, Thermo Fisher Scientific, Bremen, Germany, was utilized. The used sample introduction 
systems consist of a concentric nebulizer, a cyclone spray chamber and nickel cones (all 
from the instrument supplier). The operating conditions as well as the method and 
measuring parameters of the HR-ICPMS are summarized in Table 5.2. Sample pretreatment 
and analysis were carried out in a cleanroom facility class 10,000.
 All samples containing cell media, were analyzed with a Postnova AF1000 system 
(Postnova Analytics GmbH, Landsberg, Germany) consisting of an Asymmetric Flow-Field-
Flow Fractionation (AF4) module for particle size separation coupled serially to an ICPMS. 
The instrumental settings of the AF4 and the developed method are given in Table 5.2. F 
or the elemental detection and quantification, the out flow of the AF4 system was further 
coupled to the nebulizer of an ICPMS type XSeries II (Thermo Fisher Scientific, Breda, the 
Netherlands). The sample introduction system (all from the instrument supplier) and the 
instrumental operating conditions of ICPMS as well as the method and measuring 
parameters of ICPMS are summarized in Table 5.3. During separation processes, there is 
the possibility of analyte loss due to strong and potentially irreversible interactions; e.g. 
with the ultra-filtration membrane [20]. A calibration strategy by standard addition of the 
original nanoparticles to the matrix of interest was carried out. In addition, internal 
standard correction by continuous on-line addition of Rh solution directly after the 
fractionation and prior to the entry of the nebulizer is applied [22] for correcting variations 
in the instrument response (e.g. drift) and for calculating the analyte concentrations in 
combination with the standards.
 For several experiments, an UV/VIS detector S3206 (Sykam, Fuerstenfeldbruck, 
Germany) was additionally connected directly after the outlet of the AF4. The absorbance 
was monitored at a wavelength of 254 nm, which is typically used for the identification of 
abundant organic compounds.
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Experiments
Three series of experiments were carried out:
a) Total quantification of Ag by HR-ICPMS for the identification of the cellular uptake of 
75 nm Ag ENPs.
 The THP-1 cells were grown in RPMI 1640 medium supplemented with FCS. The cells 
were exposed to 10 μg/mL Ag of 75 nm Ag ENPs. The time- and medium composition 
dependent uptake was studied during a period of 0 to 14 h. Dilutions of the Ag ENPs 
stock solution were made with RMPI 1640 medium without and with FCS supplement. 
After the selected period of time, the cells were isolated and washed. All other details 
of the cell experiments and more variations in particle sizes and timings are described 
in [23]. The obtained cell pellets were digested with 2 mL aqua regia conc. (HNO3: HCl; 
1:3) and further diluted prior to the total quantification of Ag by HR-ICPMS.
b) Identification of Ag fractions in supernatants of cell exposure experiments by AF4-ICPMS
 After carrying out the cell exposure experiments with 10 μg/mL Ag of 75 nm Ag ENPs 
(see a)), the supernatant above the cells was collected at selected timings (after 4 and 
14 h) and the particle presence was investigated by AF4-ICPMS. The quantification is 
based on two calibration curves obtained from 20 and 75 nm Ag NPs.
c) Stability testing of Ag NPs in different cell media without cells
 The possible interaction of the cell media, this means pure media without cells, with 
Ag NPs was studied with 50 nm Ag NPs at the concentration level of 10 μg/mL Ag of 
50 nm Ag NPs. Both cell media (RPMI 1640 without and with FCS) were investigated. 
All samples and spikes were freshly prepared within 1 h prior to qualitative analysis by 
AF4-ICPMS.
Table 5.1   Operating and measurement conditions of HR-ICPMS
Parameter Setting
RF power [W] 1250
Cool gas flow [L/min Ar] 16
Nebuliser gas flow [L/min Ar] 1.04
Auxiliary gas flow [L/min Ar] 0.8
Isotopes 107Ag+ (quantification), 109Ag+ (control), 
103Rh+ (internal standard: on-line addition: 1:1)
Method Acquisition mode: E-scan
Mass window: 150%
Search window: 150%
Integration window: 80%
Sample time: 50 ms
Samples per peak: 10
Detection mode: triple
Number of replicates 9
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Table 5.2   Instrumental configuration as well as method and measuring parameters of AF4
Parameter Setting
Ultra filtration membrane Regenerated cellulose (RC), cutoff 10 kDa
Spacer / channel: height 350 µm
Eluent 0.01% SDS in ultrapure water
Injection volume 100 µL
Channel out flow 1 mL/min
1.Rinsing
Injection flow 0.5 mL/min
Focus flow 1.5 mL/min
Rinse time 60 s
2.Injection and focusing
Injection flow 0.1 mL/min
Focus time 700 s
3.Fractionation
Cross flow 0.5 mL/min
Time 30 s
Cross flow 0.8 mL/min
Time 72 min
Table 5.3   Sample introduction system, instrumental operating conditions and  
measuring parameters of ICPMS 
Sample introduction system
Operation mode On-line mixing of eluent (0.01% SDS in ultrapure water) and 
acidified internal standard (20 µg/L Rh in 2% HNO3), 1:1
Nebulizer Concentric nebulizer; pumped mode
Spray chamber Stable sample introduction system 
(cyclone - double pass spray chamber)
Cones Nickel
Instrumental operating conditions
RF power 1000 W
Cool gas flow 13 L/min Ar
Auxiliary gas flow 0.7 L/min Ar
Nebuliser gas flow 0.75 L/min Ar
Measuring mode No collision cell technique (CCT) applied
Isotope (internal standard) 107Ag+ (103Rh+)
Measuring mode Time resolved analysis (TRA)
Dwell time 300 ms
Resolution Standard
Run time 85 min (and longer)
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Results and Discussion
For the interpretation of in vitro uptake studies, it is crucial that sufficient information on 
the particle stability of the chosen ENPs under the given experimental circumstances is 
available. Therefore, three complementary, experimental series (a) to c)) by HR-ICPMS and 
AF4-ICPMS were setup for the understanding of matrix effects and uptake processes in 
relation to medium-sized Ag NPs and human cell line THP-1 as well as cell media with or 
without FCS supplement. 
For each experimental series, the results are presented and discussed in detail.
a) Time dependent cellular uptake of 75 nm Ag NPs by total quantification with HR-ICPMS
 The analytical method applied for the total quantification of Ag in cells was developed 
based on own experience of the quantification of noble metal nanoparticles in 
biological matrices [24]. The use of aqua regia as digestion media for nanosilver is 
more advantageous in comparison to nitric acid since in biological matrices also silver 
chloride (AgCl) is formed which is not dissoluble in nitric acid but which will be 
dissolved in aqua regia by forming a complex of silver di chloride (AgCl2)− [25]. The 
measurement method was optimized and the settings are given in Table 5.1. Due to 
the absence of poly-atomic interference, the measurements were carried out in low 
resolution mode of the HR-ICPMS which leads to the highest sensitivity.
 The time dependent uptake of 75 nm Ag ENPs by exposed THP-1 cells in cell culture 
media was monitored at five time points (0, 2, 4, 8, and 14 h) with regards to two 
different cell culture media. The related uptake curves are given in Figure 5.1. Both 
curves show a first increase of Ag concentration already after 2 h and uptake stability 
is achieved after 8 h. However, the related concentrations are significantly different. 
While the THP-1 cells in cell culture medium without FCS show an uptake of around 
50% of the exposed Ag amount, the uptake of Ag by the same cells in the FCS rich 
medium is drastically lower with only around 15%. Already, these first experiments 
show that the composition of culture media is of great influence on the uptake of the 
selected medium-sized Ag ENPs. Within this study, the abundance of ionic Ag in the 
original nanoparticle suspensions or in mixed culture media was not further studied. 
It is known that especially for bio-available Ag ENPs and if these ENPs are additionally 
of smaller sizes (< 20 nm), this might be of influence [14].
b) Identification of Ag fractions in supernatants of cell exposure experiments by AF4-ICPMS 
and balance of in vitro experiments
 Next to the total quantification of Ag in cells (see a)), the remaining supernatant of the 
spiked cell media after THP-1 cell exposure was identified, integrated and quantified 
for the abundances of containing Ag particles. For this approach, supernatants of 75 
nm Ag ENPs from two timings (after 4 h and 14 h of exposure) were selected and 
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analyzed by AF4-ICPMS. During the method development by AF4-ICPMS, the most 
relevant aspect for method optimization deals with the study and the handling of 
matrix effects from various in vitro relevant matrices. Details about the optimized 
conditions are described under Material and methods. Obtained fractograms showed 
one resp. two fractions. The particle identification and the quantification of the 
smaller particle size fraction (range: < 20 nm) were done in relation to 20 nm Ag ENPs 
while the larger fraction was matched with 75 nm Ag ENPs. Both calibrations were 
carried out as two-point-calibration of Ag ENPs diluted with eluent matrix (SDS). The 
on-line addition of an internal standard was used to control the general stability of 
the system; in this case no specific internal standard correction was applied. The 
results for both timings and both cell media are given in Figure 5.2.
After both timings (4 h and 14 h) different composed supernatants were identified for 
both cell culture media. In the cell culture medium without FCS (see Figure 5.2, left), already 
after 4 h no 75 nm Ag ENP fraction could be identified. However, a significant concentration 
of around 10 μg Ag/mL supernatant was determined in the particle fraction up to 20 nm, 
while this concentration further decreased to 4 μg Ag/mL supernatant after 14 h.
Figure 5.1  Time dependent uptake of 75 nm Ag by exposed macrophages THP-1 cells in 
cell culture media of different compositions.
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With FCS supplemented medium (see Figure 5.2, right), two fractions of particles were 
identified at both timings (4 h and 14 h). In this case, also particles of the originally spiked 
75 nm Ag ENPs fraction are still abundant. While after 4 h, the 75 nm Ag is strongly 
abundant also a low concentration of smaller particles (< 20nm) is measured. After14h, 
the concentration of 75 nm AgENPs is decreased, but comparable concentrations of b 
20 nm and 75 nm Ag ENPs are still abundant. Altogether, it is shown that 75 nm Ag ENPs 
are instable in the “normal” cell culture medium in comparison to the cell culture medium 
with FCS. The presence of serum plays an important role and the story is further 
Figure 5.2  Ag concentrations from spiked 75 nm Ag ENPs in supernatants of cell media 
with different compositions; after 4 resp. 14 hours of cellular contact. Quantification of two 
fractions in relation to known concentrations of 20 nm Ag ENPs resp. 75 nm Ag ENPs in 
eluent matrix.
Table 5.4   Balance between cellular included Ag and Ag fractions in supernatants 
after 14 h exposure of 75 nm Ag ENPs (10 µg/mL Ag) in THP-1 cells with 
different media
Sample Uptake of total 
Ag by cells; 
(Experiment a) 
[µg/mL Ag]
Supernatant: 
First fraction
(Experiment b)
[µg/mL Ag]
Supernatant:
Second fraction 
(Experiment b)
[µg/mL Ag]
Total 
recovery
[%]
Medium 4.75 5 < 0.5 98
Medium + FCS 1.35 4 5 104
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complicated by the capacity of ENPs to interact with, and potentially disturb the 
functioning of biomolecules such as proteins, enzymes and DNA as well as to generate 
reactive oxygen species [26]. 
 After 14 h, a steady-state situation is reached (see Figure 5.1) and the balance between 
cellular included Ag and Ag fractions in supernatants was made by combining results 
from the total quantification of Ag in cells (see a) and the obtained concentrations of Ag 
in fractions of supernatant. These results are given in Table 5.4. While estimated, expanded 
measurement uncertainties from both procedure (a) and b)) of 15 to 20 % must be taken 
into account, the total recovery of Ag for both experiments (with and without FCS in cell 
culture medium) are comparable and in the range of 98 to 104 %.
c) Stability testing of Ag NPs in different cell media without cells
 As shown with the experimental series b), the medium composition is of great 
importance on the uptake process and the particle stability. By excluding the presence 
of THP-1 cells, it is possible to study direct, possible interactions of Ag ENPs with cell 
culture medium which was used without or with FCS. The analysis was also carried out 
by AF4-ICPMS and 50 nm Ag ENPs were used for these test. All obtained fractograms 
are shown in Figure 5.3. The black fractogram obtained from “pure” 50 nm Ag ENPs in 
eluent shows a maximum fraction at a retention time of 35 min and a void peak of 
smallest, not separated Ag ENPs. After spiking the same 50 nm Ag ENPs to cell culture 
medium, a broader fraction of Ag ENPs becomes abundant and the recovery of Ag 
ENPs in the presence of the medium is lower (see green fractogram).
 Using the cell culture medium supplemented with FCS, effects in the elution profile are 
observed and in principle three fractions can be identified (see blue fractogram). Next 
to the fraction of 50 nm Ag ENPs at 35 min and the void peak, a third, significant fraction 
of Ag species of lower size with a retention time of 23 min is identified between both 
known fractions. The experiment of 50 nm Ag ENPs in cell culture medium supplemented 
by FCS was measured by AF4-ICPMS but also an intermediate UV/VIS detection at 
254 nm; see text in Figure 5.3. Only the first fraction with a retention time of 11 to 15 min 
could be confirmed by UV/VIS and the fractogram showed the same curve progression. 
As long as 254 nm is a typical absorbance wavelength for the detection of separated 
proteins and/or dissolved organic compounds [27]; therefore it can be assumed that 
Ag+ protein complexes are formed and/or that especially the smallest Ag ENPs or Ag+ 
are surrounded by the so called protein corona (PC) [28]. ENMs readily associate proteins 
that form a PC on their surface, while this PC influences the ENMs surface characteristics 
and may impact their interaction with cells. The identification and quantification are 
possible by label-free liquid chromatography double mass spectrometry (LC-MS/MS). 
Already studied Ag ENPs (20 and 110 nm with citrate coating), which agree with the 
materials used in this study, are associated with a common subset of eleven proteins 
including albumin, apolipoproteins, keratins, and other serum proteins [28].
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Conclusions
With the investigations carried out in this study, a relevant method to determine the 
stability of medium-sized nanosilver in cell media by AF4-ICPMS is developed. Relevant 
insight in the stability and the interpretation of uptake scenarios of Ag ENPs by different 
complex cell media of the macrophage THP-1 cell line are obtained which explains 
different uptake results. The great influence of (fetal calf) serum on the stability of nanosilver 
was confirmed, which can be associated with a protein corona effect or by Ag+ complexes 
with proteins. Applying only the “classical” approach of acid dissolution followed by the 
total quantification by ICPMS might otherwise lead to incomplete or wrong conclusions 
in nanotoxicity studies by in vitro experiments.
 It is shown that the nature of the matrix appears to affect the stability of Ag ENPs 
strongly. It is shown that transformations occur within a few minutes after the addition of 
the Ag ENPs to the medium. This effect was also observed in other aqueous matrices like 
domestic waste water [20].
 The time dependent presence of various sized and composed particles has been also 
confirmed. By the presence of cells further particle change processes take place.
The identification of AgNPs associated with cells can also help to better understand the 
mechanisms of toxicity of the NPs. However, due to the larger particles sizes, also other 
Figure 5.3  Fractograms by AF4-ICPMS obtained of identical concentrations (0.5 µg/mL 
Ag) of 50 nm Ag ENPs spiked to two different cell media versus the reference fractogram 
of “pure” 50 nm Ag ENPs in eluent.
Only rst fraction (11 to 15 min) was also conrmed 
by AF4- UV/VIS 254 nm: same course
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field flow fractionation approaches, e.g. by sedimentation (SdFFF) should be studied more 
closely and might be more advantageous [29].
 Regarding all analytical results in this study, it can be concluded that a promising 
platform by HR-ICPMS and AF4-ICPMS is developed for obtaining insights into the stability 
of nanosilver and the cellular uptake in in vitro systems. This tool will enable a better 
control and monitoring of Ag ENPs in in vitro tissue culture media, and in vitro assay 
systems.
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Abstract
The ever increasing number of nanoparticles cannot all be tested separately for their 
(cellular) uptake and possible subsequent toxicity. The prediction of the extent to which 
spherical nanoparticles are taken up by living cells is highly desirable for risk assessment. 
We tested the hypothesis that cellular nanoparticle uptake follows (quasi) first-order 
kinetics. Furthermore, we determined whether the values of the parameters of first-order 
kinetics are correlated to easily measurable NP properties such as size or charge to derive 
QSARs. Nanoparticle uptake often follows first-order kinetics for different nanoparticles, 
cell lines and experimental conditions. Neither nanoparticle size nor charge appear to be 
correlated with the parameters of first-order kinetics. Other factors than size and charge 
influence uptake kinetics more strongly.
Keywords
cellular uptake; first-order kinetics; modelling; nanoparticle; QSARs
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Introduction
Engineered nanoparticles are used in increasing amounts and numbers of applications 
due to the often occurring change in properties with decreasing size in comparison to the 
bulk material of the same chemical composition [1-3].They are widely applied in the field 
of electronics and as industrial catalysts and they are part of numerous consumer products 
such as sportswear and personal hygiene products. In addition, they are also used in the 
medical field as drug delivery systems and diagnostic tools [4-8]. The widespread 
application of NPs may lead to unwanted exposure of humans, during production, use 
and disposal of NP containing products.
 The same properties that render NPs interesting for the new fields of application 
mentioned (their small size and high reactive surface area), may lead to unintended 
biological impacts due to their ability to access the cellular machinery. In contrast to many 
traditional chemicals that diffuse freely in or out of a cell, NPs enter the cell by energy-de-
pendent pathways as do proteins and other biomolecules. Once humans or biota come 
into contact with NPs via one of the four exposure routes (inhalation, dermal or intestinal 
uptake, injection for medical use), uptake into cells via a fundamental biological process 
called receptor-mediated endocytosis (RME) becomes possible [9, 10]. RME is an active 
uptake mechanism employed by nearly all eukaryotic cells to take up small molecules and 
nutrients from the surrounding medium via enclosure by the cell membrane. The resulting 
vesicles reach sizes up to 120 nm in diameter [11, 12]. The cargo size determines the vesicle 
size to some extent, yet the maximum vesicle size is species and cell type dependent [13, 
14]. Therefore, these vesicle sizes are not rigid, but their size is most likely limited to allow 
only cargos of defined sizes to enter cells [15]. Specialized mammalian cells can employ 
an additional uptake mechanism called phagocytosis. It is a ligand-induced process by 
which particulate matter with sizes of 0.5 to 10 µm is taken up. This mechanism is usually 
employed by cells of the immune system in order to clear the body from cell debris and 
foreign cells [16]. NPs can enter cells via this mechanism [10].
 Uptake kinetics describe the ability of NPs to cross natural barriers, influencing their 
ability to cause toxicity. Many toxicity studies have been conducted and negative health 
impacts have been found (to a larger extent than for the same element in ionic form) [17], 
for example through the formation of reactive oxygen species or depletion of the amount 
of antioxidant species in the cell [18, 19]. Therefore, the extent to which NPs are taken up 
into cells over time is a factor to be considered in toxicity assessment. Cellular uptake is 
listed as one toxicological endpoint to be addressed for the risk assessment of 
nanomaterials under REACH (Registration, Evaluation, Authorization and Restriction of 
Chemicals) [20]. Prolonged exposure times lead to increased internalized NP concentrations. 
The present paper focuses on predictive quantification of the extent of uptake of NPs by 
living cells. The increasing risk related to NP exposure in combination with the ever-in-
creasing amount of different NPs (core material, surface coating, size, charge…), raises the 
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question whether it is possible to relate NP uptake kinetics to easily measurable NP 
properties. This would allow to overcome the obstacle that not every type of NP can be 
tested for uptake and toxicity. The NP properties determining NP uptake kinetics are 
currently of growing interest for safe implementation of nanotechnology [6, 21, 22] and 
medical applications such as drug delivery [23, 24]. Correlating uptake to easily measurable 
NP properties such as size facilitates prioritization for toxicity and bioaccumulation 
potential.
 Several studies report NP uptake in dependence of NP size [13, 25-29]. Unfortunately, 
uptake is often determined after a fixed time point and does not represent uptake over 
time. Blechinger et al. demonstrate the importance to compare  uptake efficiencies 
(between cell lines) also over time [30]. The number of NPs taken up by HeLa cells within 
the first 4 hours was lower than for HUVEC cells. The opposite was the case at longer 
exposure times due to increased uptake kinetics. Such studies lead to increased 
understanding of uptake mechanisms and enhance the accuracy of risk assessment. 
Studying uptake and elimination over time is often assessed to determine accumulation 
of traditional chemicals. Some studies determine uptake of NPs over time [31-33]. Yet, 
these studies are usually limited either to different particles in only one cell type or vice 
versa. In addition, the effect of NP concentration, NP properties (size and charge), cell line 
and serum on uptake is rarely addressed. It is, therefore, of practical importance to explore 
options for modelling.
 In this study, we have tested whether uptake can be described by first-order kinetics 
and derive the adjacent parameters’ value. We have also attempted to derive QSARs that 
describe the parameters of first-order uptake as a function of NP properties.
Material and Methods
Data collection
As only a few sources published data from parameters of (first-order) uptake kinetics, we 
collected data from studies that determine NP uptake in dependence of NP properties or 
experimental conditions. A literature search was conducted via Web of Science and 
Google Scholar, using the following key words in various combinations: nanoparticles, 
(cellular) uptake, (receptor-mediated) endocytosis, time-dependent, kinetics. The studies 
had to fulfil the following prerequisites. Cellular concentrations of NPs over time had to be 
reported and particle sizes were limited to a maximum of 120 nm in diameter according 
to the ubiquitous uptake mechanism. Besides these prerequisites, no further restrictions 
have been placed on the selected publications to allow for sufficient data to be collected. 
Due to their different uptake mechanisms non-phagocytic and specialized phagocytosing 
cell lines were analyzed separately. 
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The data collection resulted in 21 studies that meet the mentioned criteria. Seven of these 
studies tested cell lines known to be phagocytes (e.g. THP-1, RAW 264.7, HUVEC). This 
resulted in 54 data for non-phagocytes and 38 for phagocytes. The number of data 
obtained for various size classes are given Table 6.1. These data cover a broad range of NP 
types (e.g. gold, silica oxide, polystyrene), surface modifications (e.g., citrate, poly(allyamine 
hydrochloride), poly(vinyl alcohol)) and cell lines (e.g., HeLa, HBE, A549). The cell lines were 
first grouped according to their origin, i.e. from animals or humans. The particle sizes 
reported here are those measured in the exposure medium whenever possible. If this 
information was lacking due to the detection method (e.g. transmission electron 
microscopy TEM), the core size excluding a protein corona is used here. If no measurement 
of aggregation was conducted, the concept of primary particle size was assumed to be 
valid.
Data treatment
Data sources reported uptake data obtained with various detection techniques, e.g. flow 
cytometry, confocal scanning microscopy, fluorescence-activated cell sorting, ICP-MS. We 
extracted uptake data from the published figures by means of the software package 
‘Digitize it’ (http://www.digitizeit.de). Conversion to NP numbers or fluorescence intensity 
was necessary to allow for comparison between uptake data from different studies. 
Uptake data given in units other than fluorescence intensity or NP numbers, were 
Table 6.1   Number of published data points for various NP size classes, distinguished for 
non-phagocytes and phagocytosing cells.
NP size [nm] No of data non-phagocytes No of data phagocytes
0< NP ≤ 10 2 2
10< NP ≤ 20 8 1
20< NP ≤ 30 2 2
30< NP ≤ 40 3 1
40< NP ≤ 50 6 -
50< NP ≤ 60 1 -
60< NP ≤ 70 2 4
70< NP ≤ 80 7 -
80< NP ≤ 90 8 1
90< NP ≤ 100 11 1
100< NP ≤ 110 1 1
110< NP ≤ 120 3 25
104
converted to NP numbers according to Chithrani et al. [31]. If no conversion was possible, 
data were discarded. Amounts of NPs (i.e. numbers of particles) were expressed as 
dimensionless ratios to the theoretical maximum NP number accumulated at steady state. 
Observed particle numbers taken up at time t were scaled to the expected value at infinite 
time per study, so that all relative amounts taken up would range between zero (at t=0) 
and 1 (t=∞), regardless of the original units of measurement. The theoretical maximum 
concentration of NPs was calculated for the NP with the highest observed concentration 
per study. This allows easier fitting and interpretation of the rate parameters from the 
reported amount-time series.
Model
The normalized (dimensionless) uptake amounts were then fitted to a first-order one- 
compartment model [34]. Such a model takes the uptake rate u (in dimensionless relative 
uptake units per hour) and the first order elimination rate constant ke [hour-1] into account 
as shown in Equation 6.1. Uptake has been observed in the numerous studies described 
here. Elimination, also called exocytosis, describes the reduction of the concentration in 
an organism or cell after refreshment of the medium without a chemical; it has been 
occasionally observed [32, 35, 36]. In our model, we express the relative NP uptake rate per 
hour:
Equation 6.1
Nc(t) =
Nm ·
ku · (1 – e–ket) =
u
ke
· (1 – e–ket)
Nc(∞) Nc(∞) ke
where Nc (t) is the amount of nanomaterial [unit] taken up by cells after exposure of t hours 
to a medium containing Nm particles [unit], Nc (∞) is the amount of nanomaterial from the 
medium, u (=ku·Nm/Nc(∞)) is the relative uptake rate [hour-1], ke is the first-order rate 
constant of removal of nanomaterial from the cell per hour, and t [hours] is the time of 
exposure. The units of measurement are either number of nanoparticles or fluorescence 
intensity. The quotient u/ke represents the relative amount taken up at infinitive time. 
For simplicity, the relative NP uptake rate will be called ‘NP uptake rate’ here after.
 We tested the hypothesis that NP uptake follows first-order kinetics, as proposed 
before [37-39]. The results were evaluated with Microsoft Excel 2010 and the corresponding 
application ‘Solver’. Solver is a tool that determines the optimal values for variables, here u 
and ke, to minimize differences between experimental and model data.
 To provide a measure of the goodness of fit between observed and model data, the 
squared Pearson product-moment correlation coefficient r2, as calculated with the “RSQ” 
function in Excel based on fractions, was reported. 
 Next, we wanted to relate uptake parameters to NP properties by so called QSAR- 
models. The Excel 2010 add in ‘Analysis ToolPak’ was used to derive regressions with the 
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variables ‘diameter’, ‘zeta potential’, ‘surface area’, ‘volume’ and a multivariate regression 
using the two variables ‘diameter’ and ‘zeta potential’ at the same time to detect whether 
they are good descriptors of uptake. The confidence interval was set to 95%. This add in 
also automatically provides a measure of the goodness of fit of the regressions, called r2. 
In addition, the Excel add in ‘Solver’ was used to determine whether the fitted model 
parameters u and ke are normally distributed or whether they can be fitted through a 
linear or parabolic regression. As an additional, absolute error measure, the root-mean-
square error (RMSE) was calculated according to the following equation:
Equation 6.2
RSME =
1
× Σ n (0i – Pi)2
n i=1
where n is the number of data points, Oi the observed value, and Pi the predicted value. 
Calculating the average difference between the measured values and predicted ones, 
takes into account both systematic bias and random error [40].
Results
We have used the one-compartment model described by Equation 6.1 to test whether 
uptake of nanoparticles in cells obeys first-order kinetics. Results for phagocytes and 
non-phagocytes are presented separately. In the vast majority of cases, model and data 
matched well, resulting in a high explained variance (0.8 and higher, see Table S 6.2). 
For one study, the model did not fit the data for the two tested conditions sufficiently [41]. 
In the case where cells were exposed to NPs in the presence of serum, the one 
compartment model resulted in an r2 of 0.23. In experiments without serum, the original 
curve is not smooth and cannot be matched well with the model curve. In another case 
the original curve is not smooth and the deviations between data and model resulted in 
very high values for u and ke [39]. Due to the differences between data and model curve, 
these results were excluded in our calculations. For non-phagocytes, the uptake rates u 
varied between values of nearly 0 to roughly 27 [hour-1]. First-order elimination rate 
constants ke [hour-1] differed from values of nearly zero to approximately 37, the latter of 
both being exceptionally high and belonging to the unsmooth curve mentioned before. 
Values of uptake rates u ( [hour-1] found in the experiments analyzed are given in Table S 6.1.
 For non-phagocytes, approximately one third of the samples had calculated uptake 
rates u ≤ 0.1 [hour-1] (Table 6.2, Figure 6.1). The second and third largest amount of data 
points fell in the range of u ≤ 0.2 [hour-1] and u ≥ 1.0 [hour-1]. Therefore, uptake rates were 
similar in magnitude for different NPs and across various cell lines for approximately 50 % 
of published data. Yet, 17 % of the data showed rather large uptake rates in comparison. 
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Neither the fitted normal distribution nor a linear relationship could describe the observed 
data well, leading to a low r2 of approx. 0.053 and 0.009, respectively (Table S 6.1).
Table 6.2   Percentage of observed data points per decimal step of the first order  
uptake rate u.
Observed number of data points
[% of total, rounded to full 
numbers] NP size
Observed number of data points
[% of total, rounded to full 
numbers] NP charge
Uptake rate u 
[hour-1]
Non-phagocytes Phagocytes Non-phagocytes Phagocytes
u ≤ 0.1 37 38 32 32
0.1 < u ≤ 0.2 21 17 16 9
0.2 < u ≤ 0.3 4 7 13 15
0.3 < u ≤ 0.4 4 0 8 9
0.4 < u ≤ 0.5 6 7 3 3
0.5 < u ≤ 0.6 2 - 16 18
0.6 < u ≤ 0.7 - 5 - -
0.7 < u ≤ 0.8 4 - - 6
0.8 < u ≤ 0.9 2 2 5 -
0.9 < u ≤ 1.0 4 2 3 3
u ≥ 1 17 21 5 6
Figure 6.1  Percentage of observed data points per decimal step of the uptake rate u 
[hour-1] for non-phagocytes.
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We observed (Figure 6.2) that the same type of NP may lead to different uptake rates in 
various cell lines [33, 42-44]. This was most pronounced for the tested cell lines of Harush- 
Frenkel et al.  2007. Uptake kinetics were, therefore, slightly variable between cell lines. 
The exposure concentration may have a similar effect on uptake rates as demonstrated 
by several studies [39, 44, 45]. The tenfold higher exposure concentration also lead to a 
roughly 7-fold increase of the uptake rate [45]. Kim et al. also studied the effect of exposure 
concentrations on the uptake rate, using a concentration 4 times as large as the low 
concentration. This lead to an approximately 2.5 fold increase of the uptake rate [44].
The number of studies and number of data point for phagocytes was much smaller than 
for the non-phagocytes. With the indicated key words only 7 studies with 38 data points 
were found that fulfil the mentioned criteria. Some of the measurements that lead to 
this number of data points were counted double because they are compared in different 
sub groups within one study. 
Figure 6.2  Uptake rate u [hour-1] for non-phagocytes in dependence of the NP diameter 
[nm]. Open symbols represent studies with animal cell lines, closed symbols data from 
human cell lines. The shape of the data points are used to distinguish the applied dose 
metrics: same NP number (circles), same mass (triangle), unknown/not applicable (squares). 
Please notice the log scale of the y-axes.
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Lunov et al. 2011, for example, studied the effect of the  differentiation status of cells, 
the presence or absence of serum and NP charge [46]. Therefore, the data were divided 
into three sub groups which results in 24 data points from 8 observations.
 Similar to non-phagocytes, roughly one third of the data points for phagocytes had 
uptake rates u ≤ 0.1 [hour-1] (Figure 6.3). The group of calculated uptake rates u ≥ 1.0 [hour-1] 
is smaller and only comprises roughly 5 percent of the total data points. Phagocytes data 
were scattered due to variability in the uptake rate for different cell lines but the same NP 
[46, 47], in dependence of the exposure concentration [35, 45] and the presence or 
absence of serum [46] (Figure 6.4).
Little similarity in the distribution of uptake rates of non-phagocytes and phagocytes 
could be observed when only those studies were considered where the NP’s charge was 
reported (Figure 6.5, Figure 6.6). Not all studies determined the zeta potential, therefore 
this data set was smaller; 34 instead of 38 data points (phagocytes) and 42 instead of 54 
(non-phagocytes).
Figure 6.3  Percentage of observed data points per decimal step of the uptake rate u 
[hour-1] for phagocytes.
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To test whether other variables might be a better descriptor of uptake rates than the NPs 
diameter, r2 was also calculated for the uptake rates in relation to the surface area, volume, 
zeta potential/charge and combination of diameter and charge (Table S 6.1). Uptake rates 
could not be explained sufficiently by either of the applied descriptors, neither for 
phagocytes nor non-phagocytes. There seemed to be no clear relationship between 
uptake rate and particle size (Figure 6.7, Figure 6.8), as also demonstrated by the overlap 
of the calculated 95% confidence intervals (Table 6.3).
Figure 6.4  Uptake rate u [hour-1] for phagocytes in dependence of the NP diameter [nm]. 
Open symbols represent studies with animal cell lines, closed symbols data from human 
cell lines. The shape of the data points are used to distinguish the applied dose metrics: 
same NP number (circles), same mass (triangle), unknown/not applicable (squares). Please 
notice the log scale of the y-axes.
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Figure 6.5  Uptake rate u [hour-1] for non-phagocytes in dependence of the zeta potential. 
Open symbols represent studies with animal cell lines, closed symbols data from human 
cell lines. The shape of the data points are used to distinguish the applied dose metrices: 
same NP number (circles), same mass (triangle), unknown/not applicable (squares). Please 
notice the log scale of the y-axes.
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Figure 6.6  Uptake rate u [hour-1] for phagocytes in dependence of the zeta potential. 
Open symbols represent studies with animal cell lines, closed symbols data from human 
cell lines. The shape of the data points are used to distinguish the applied dose metrices: 
same NP number (circles), same mass (triangle), unknown/not applicable (squares). Please 
notice the log scale of the y-axes.
Figure 6.7  Average observed uptake rate log u [hour-1] in dependence of NP size for 
non-phagocytes within 20 nm bins. Error bars represent the 95% confidence interval.
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Figure 6.8  Average observed uptake rate log u [hour-1] in dependence of NP size for 
phagocytes within 20 nm bins. Error bars represent the 95% confidence interval.
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Table 6.3   95% confidence intervals (CI) of the uptake rate log u [hour-1] per NP size 
class for non-phagocytes and phagocytes.
NP size class Lower end 95 % CI Upper end 95% CI Average
Non-phagocytes
0-19 -1,587 -0,610 -1,098
20-39 -1,093 -0,360 -0,727
40-59 -1,425 0,344 -0,540
60-79 -0,731 -0,032 -0,381
80-99 -1,397 -0,257 -0,827
100-119 -1,954 -0,898 -1,426
Phagocytes
0-19 -1,022 -0,744 -0,883
20-39 -1,031 -0,485 -0,758
40-59 - - -
60-79 -1,508 0,006 -0,751
80-99 - - -0,932
100-119 -1,187 -0,566 -0,877
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Discussion
In this study, data from studies on a mass basis were first converted to NP numbers taken 
up. Next, NP number values were expressed as dimensionless fractions of the theoretical 
maximum NP number accumulated to test the hypothesis that uptake follows first-order 
kinetics. The good fit between the converted data and first-order one-compartment 
model demonstrated that uptake of NP into living cells obeys first-order kinetics. Only in 
two  cases data and model did not fit well [41]. In this case the data points did not result in 
a smooth curve, likely due to the high standard deviation for some of the data points. In 
the other case serum was added to the exposure medium, which might lead to the 
formation of a protein corona on the NPs’ surface and aggregation as discussed further 
later on.
 In each data set, values of u and ke were obtained by fitting a first-order, two-parameter 
model of equation (6.1) to the normalized amounts taken up. The obtained quotients u/ke 
were close to one for the NPs that uptake values were normalized to, indicating that the 
calculated maximum amounts of uptake had reached the steady-state level sufficiently 
close. We normalize to the number of NPs internalized at steady state for the NP with 
highest observed uptake per study. Whether a higher uptake would be possible for a 
different untested NP was unknown.
 Since our work covered different NP core materials, coatings, charges, cell lines, and 
experimental set ups, such as presence or absence of serum during incubation, we 
investigated whether uptake kinetics follow a more fundamental mechanism and whether 
some more general conclusions about NP uptake kinetics can be drawn. Having shown 
that uptake can be described by first-order kinetics, we attempted to derive QSARs that 
predictively describe the parameters of first-order uptake as simple functions of NP 
properties such as size and charge. Large scattering of the data was observed and no 
predictive QSARs could be derived; there was no clear relationship between the 
parameters of first-order uptake and the NP properties ‘size’ and ‘charge’.
 Several studies suggested that a NP size of approximately 50 nm in diameter leads to 
the highest NP uptake [13, 25-29]. This is the size range in which many naturally occurring 
endocytosis targets, such as viruses and lipid carrying proteins, fall [28]. Unfortunately, the 
size optimum was determined after a fixed time point in those references and did not 
represent uptake over time. The importance to determine uptake over time to compare 
uptake efficiencies (between cell lines) was nicely demonstrated by Blechinger et al. [30]. 
Uptake in HeLa cells started off slowly with low amounts taken up within 4 hours. At 10 h 
and 24 h uptake increased drastically, reaching much higher intracellular concentrations 
in the end than HUVEC cells for which uptake kinetics where fast at the beginning. 
Knowledge on kinetics, in addition to static conditions, generally improves the under- 
standing of uptake mechanisms and enhances the accuracy of risk assessment. Due to the 
importance of NP safety it is, therefore, of practical importance to explore effects of NP 
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properties, such as size, on uptake. Uptake and elimination over time is often assessed to 
determine accumulation of traditional chemicals. Some studies determined uptake of NPs 
over time and observed that there is a size where the uptake of NPs into cells was 
maximized [31-33]. Yet, these studies proposed this optimum based on data from their 
own conducted experiments only. Therefore, they were usually limited either to the use of 
different particles but only one cell type or vice versa. The combination of both within one 
study was scarce. The effect of concentration on NP uptake rates was rarely taken into 
account.
 The size-optimum of endocytosis for few studies and a limited set of data points has 
been confirmed and explained by various models that describe how many NP can be 
internalized or how fast NPs can be internalized depending on their size, taking into 
account the competitive binding energy between NPs and receptors and the energy 
required for the wrapping of the NPs [48-50]. In their theoretical model, Zhang et al. 
assumed an average receptor density and average area of the plasma membrane. Yet, as 
discussed later, the size and corresponding surface area of cells might largely vary and it is 
well known that the amount of expressed receptors is often increased in cancer cell lines 
[51, 52]. 
 Despite suggestions of 50 nm as an optimal uptake size based on (equilibrium) 
accumulation, our study suggests that other factors matter more than NP size. The 
discrepancy might be explained by several factors related to the lack of a straight forward 
methods to evaluate NP uptake of different sizes or, even more so, standard test protocols 
and materials. 
 First, several factors related to the experimental setting may explain why a 
generalization that uptake is (dominantly) NP size controlled is not possible: Dose metrics 
differed in the presented studies; either a constant mass was applied or a fixed number of 
NPs, with mass being the most common one because it is highly practical and convenient. 
A third, rare option is the application of a fixed volume, which we did not observe here. 
Exposure concentrations differed from study to study. The amount of NPs taken up after a 
fixed time point as well as uptake kinetics depended on the exposure concentration 
[37-39, 44, 45, 47, 53, 54]. Higher exposure concentrations lead to higher uptake until a 
saturation concentration was reached. The higher uptake at higher exposure concentrations 
seemed to be related to higher attachment of NPs to the cell membrane [55]. Curves 
relating uptake after a fixed time point to exposure concentration were non-linear and 
their slopes differed between cells lines [54]. The attachment efficiency of NPs to the cell 
membrane and subsequent uptake into cells depended also on the delivery of the NPs to 
the cells via diffusion and settling in cell culture medium, so called particokinetics, as 
further described elsewhere [56-58]. Under some conditions the delivery of NPs to the cell 
was slower than the removal of the particles from the medium through uptake by cells. In 
this case the low delivery rate would be the rate-limiting factor for uptake [59]. Therefore, 
incorporation of particokinetics in the study design or as a mean to evaluate experimental 
115
6
Exploring the possibility of read-across on the extent of NP uptake
results will further help to get new insights into the NP characteristics influencing NP 
uptake and intracellular toxicity and the dynamics of NP cell interactions. Uptake data 
were expressed in numerous units, partly depending on the detection method, and the 
results can differ depending on the unit used. Levy et al showed that the size optimum 
varied with the unit in which uptake is expressed [60]. This was also nicely shown 
graphically by Yue et al. [61].
 Second, the choice of cell line influenced uptake and data to unify across cell lines 
was lacking. Uptake rate and mechanism are cell type specific, and may depend on cell 
density [44, 62, 63]. Observed differences between various cell lines but the same NP may 
be attributed to differences in the cell surface area. We assumed that all cell lines were able 
to take up the same amount of NPs when we normalized the data for each study separately. 
This was based on a study by Wilhelm et al. [45]. They showed that the iron load per cell 
after 1 h incubation at 4°C was the same for two cell lines after renormalization of the mass 
by the cell surface [45]. So the total mass taken up in dependence of the cell surface area 
could be predicted, but whether similar results could be expected for the first order rate 
constants is unknown. The binding capacity per unit surface was the same across several 
cell lines [54], and the efficiency of the adsorption of NPs onto the cell surface prior to 
uptake depended only on the cell surface. Yet, the characteristic time for internalization 
ranged from 0.4 to 1.8 hours within the tested cell lines [54], which might lead to different 
uptake rates. The publications under our investigation usually did not report cell sizes or 
surface area, therefore it was not possible to normalize NP uptake to cell properties. Values 
reported in literature differed a lot, e.g. diameters of HeLa cells were reported to range 
from 15 nm to 30 µm, corresponding to volumes of  500-5000 µm3 [64]. The small observed 
differences in rate constants between cell lines could be related to the different intended 
roles of various cells [65]. In addition to size, the membrane tension can span several orders 
of magnitude and has been shown to have large effects on the cellular uptake of NPs [50]. 
As several characteristics of a membrane already vary within one cell type [66],  we 
expected that it might also partly explain the observed differences between cell lines.
 Third, besides size and charge, other NP properties may influence their cellular uptake, 
as previously summarized [9]. Other NP surface properties that influence uptake include 
surface functional groups, hydrophilicity and lipophilicity, and even surface roughness.
 Furthermore, it is questionable whether the reported NP sizes are also those that the 
cells ‘see’. It is well known that the particle size change with the surrounding medium, e.g. 
by the formation of a so called protein corona [55]. In the presented studies the NP size 
was not always determined in the exposure medium, or via techniques that don’t allow 
the detection of a protein corona on the NP’s surface [43, 53, 67]. The formation of a 
protein corona may influence the kinetics of membrane binding of NPs rather than the 
kinetics of the actual uptake process [68].
 Besides these data and parameter uncertainties, model uncertainties may contribute 
to the discrepancy. The chosen equation may not represent the actual process exactly. 
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Yet, Excel reported a good fit between model and data with high r2 for the vast majority of data. 
The given first order rate constants were not absolute but for reasons of comparability 
between studies relative ones. Comparison of absolute values of those studies that report 
their results in NP numbers would be desirable, yet impossible in some cases because of 
a lack of information. Basic information like the number of cells per monolayer for example, 
were sometimes missing, yet indispensable for such a comparison [69].
Conclusion and recommendations
Besides the increased likelihood of NP exposure through consumer products and medical 
applications and the fact that uptake kinetics are inherently linked to toxicity assessment, 
up to now no general approach was conducted to analyze reported uptake data with 
regard to uptake kinetics. Therefore, we collected data on NP uptake kinetics, which were 
shown to follow first-order kinetics. Having collected a large data set of uptake rates, 
it remains difficult to draw general conclusions about the relationship between NP 
properties and uptake kinetics. Our paper demonstrates that variables commonly thought 
to govern uptake do not allow for modelling (yet). Predictive QSARs could not be constructed 
due to heterogeneity of data and a lack of data reported within studies. Our paper will 
guide future efforts of researchers and demonstrates which bottle necks need to be 
overcome. Therefore, we recommend to include more information in future studies to 
enable incorporation within models and to increase their predictive power. We identified 
the following information to be necessary additions: exposure concentration, NP size 
and charge in the exposure medium, cell size, surface area or volume. Especially more 
standardization, e.g. through the use of reference materials would hopefully steer research 
in the right direction [70].
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Table S 6.1. Calculated uptake rates u [hour-1] from published data for various conditions 
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Appendix
Table S 6.1   r2 using linear, normal, parabolic, and multivariate regression to relate u 
[hour-1] to the various descriptors
u [hour-1] descriptor Diameter 
[nm]
Surface 
area [nm2]
Volume 
[nm3]
Zeta 
potential
Diameter 
and charge
Non-phagocytes
Linear r2 0.009 0.007 0.011 0.035 0.038
Normal 
distribution
r2 0.053 - - - -
RMSE 0.642 - - - -
Phagocytosing cells
Linear 0.011 0.028 0.027 0.007 0.018
Normal 
distribution
r2 0.030 0.028 0.027 - -
RMSE 0.065 0.067 0.065 - -
parabolic r2 - - - 0.065 -
RMSE - - - 0.067 -
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Table S 6.2   Calculated uptake rates u [hours-1] from published data for various 
conditions and NP sizes 
Ref. Different conditions  
(where applicable)
NP size, 
diameter 
[nm]
Uptake 
rate u 
[hour-1]
r2
Non-phagocytes
[45] 15 mM 8.7 1.003 0.977
1.5 mM 0.149 0.992
[31,36] 14 0.265 0.982
[69] 15 0.026 0.995
[67] PAA 17.7 0.110 0.976
Citrate 0.018 0.996
PVA 0.010 0.989
[43] PK-1 20 0.052 0.969
PK-45 0.074 0.896
PANC-1 0.057 0.927
[27] 24 0.702 0.873
[54] 30 0.993 0.978
[33] A549 33 0.086 0.959
1321 N1 33 0.123 0.992
[27] 36 0.916 0.975
[33] A549 44 0.349 0.951
1321 N1 0.401 0.991
[165] 44 3.172 0.984
[39] 46 27.370 0.706
[31,36] 50 0.327 0.987
[69] 50 0.001 0.991
[39] 56 2.703 0.902
[41] Serum free 64 0.281 0.981
[32] 66 0.114 0.965
[31,36] 74 0.159 0.990
[39] 77 0.103 0.996
[39] 5 ug/mL 77 0.265 0.784
15 ug/mL 0.538 0.695
25 ug/mL 0.753 0.982
50 ug/mL 1.430 0.888
90 ug/mL 3.134 0.711
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Table S 6.2   Continued 
Ref. Different conditions  
(where applicable)
NP size, 
diameter 
[nm]
Uptake 
rate u 
[hour-1]
r2
Non-phagocytes
[166] HcMEC D3 84 0.027 0.999
1321 N1 0.010 0.999
A549 0.013 0.999
HeLa 0.005 0.989
[165] 86 2.183 0,995
[32] 87 0.027 0.996
[42] 89.8 0.476 0.987
[167] 89.8 5.444 0.985
[65] 95 0.431 0.985
[42] 96.4 0.197 0.971
[167] 96.4 4.592 0.981
[27] 99 0.104 0.967
[44] SH-SY5Y 100 0.021 1.000
1321 N1 0.021 0.967
hCMEC D3 0.005 0.997
A549 0.072 0.997
[44] 25 ug/mL 100 0.040 1.000
100 ug/mL 0.109 0.990
[69] 100 0.001 0.976
[41] complete medium 105 0.027 0.230
[33] A549 114 0.103 0.907
1321 N1 0.197 0.990
[165] 117 0.814 0.986
[45] 1.5 mM 8.7 0.165 0.987
0.75 mM 0.104 0.995
[168] 20 0.199 0.917
[47] Monocytes 30 0.059 0.998
Macrophages 0.273 0.997
[52] 32.2 0.289 0.989
[35] 50 µg/mL 65 0.270 0.993
100 µg/mL 0.431 0.991
200 µg/mL 0.948 0.996
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Table S 6.2   Continued 
Ref. Different conditions  
(where applicable)
NP size, 
diameter 
[nm]
Uptake 
rate u 
[hour-1]
r2
Non-phagocytes
[52] 70.7 0.009 0.983
[166] 84 0.117 1.000
[168] 100 0.002 0.959
[52] 102.4 0.004 0.952
[38] PS-NH2, HBSS, macrophages Cell line effect 113 0.212 0.924
PS-NH2, HBSS, THP-1 0.367 0.923
PS-NH2, serum, macrophages Cell line effect 113 0.322 0.860
PS-NH2, serum, THP-1 1.459 0.870
PS-NH2, HBSS, macrophages Serum effect 113 0.212 0.924
PS-NH2, HBSS, THP-1 0.509 0.963
PS-NH2, serum, macrophages Serum effect 113 0.056 0.860
PS-NH2, serum, THP-1 0.350 0.879
PS-NH2, HBSS, macrophages Charge effect 113 0.106 0.924
PS-NH2, HBSS, THP-1 0.126 0.963
PS-NH2, serum, macrophages Charge effect 113 0.026 0.860
PS-NH2, serum, THP-1 1.459 0.879
[38] PS-COOH, HBSS, macrophages Cell line effect 116 0.575 0.934
PS-COOH, HBSS, THP-1 0.567 0.885
PS-COOH, serum, macrophages Cell line effect 116 0.050 0.999
PS-COOH, serum, THP-1 0.042 0.827
PS-COOH, HBSS, macrophages Serum effect 116 0.841 0.934
PS-COOH, HBSS, THP-1 0.567 0.885
PS-COOH, serum, macrophages Serum effect 116 0.054 0.999
PS-COOH, serum, THP-1 0.031 0.827
PS-COOH, HBSS, macrophages Charge effect 116 0.841 0.934
PS-COOH, HBSS, THP-1 0.567 0.885
PS-COOH, serum, macrophages Charge effect 116 0.050 0.999
PS-COOH, serum, THP-1 0.531 0.827
[52] 118.3 0.001 0.991
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Introduction 
NPs represent a new type of chemicals that differ from traditional chemicals with regard 
to their physico-chemical properties, as well as biological interactions, in particular their 
uptake mechanism into cells. NPs a particulate in nature, as their name implies, and are 
therefore not dissolved in water like traditional chemicals. Due to their state the substances 
obtain different biological activities. In contrast to traditional chemicals, NPs are mainly 
taken up by endocytosis by the vast majority of cells [1]. Uptake via passive membrane 
penetration [2], i.e. for red blood cells, which lack the endocytic machinery [3], or via hole 
formation has been shown to be possible [1, 4]. Yet, uptake into red blood cells is very low 
with less than one NP per cell on average [5]. Therefore, this type of emerging chemicals 
requires new models that take this active mechanism into account. In order to achieve this 
goal, this thesis is focused on the following main points: 
•  First, to identify factors determining the cellular exposure to NPs, more specifically 
the extent of NP uptake (Chapter 2)
•  Second, to determine uptake kinetics in dependence of NP size into two different 
cells lines under relevant exposure concentration (Chapter 3, Chapter 4)
•  Third, development of an analytical technique for the determination of NP stability 
and abundance of NPs over time (Chapter 5)
•  Fourth, to integrate information on the cellular level into models, possibly enabling 
predictions for untested NPs through construction of quantitative structure activity 
relationships (Chapter 6).
In the following, this chapter discusses controversial results between studies, between 
the chapters mentioned above and possible causes. We point to limitations of NP uptake 
studies and the resulting uncertainties and variability within the constructed QSARs. 
We focus on those topics that caused discussion in several chapters, i.e., particle character-
ization, dose metric and exocytosis. Finally, conclusions and recommendations on how 
to improve or systematize future studies and experimental set ups to enable the 
determination of parameters that govern uptake kinetics, are given.
Discussion
Dose metric
In contrast to traditional chemicals, which will usually interact with their environment in 
their soluble form, it is the NPs particulate nature, and the resulting differences in size and 
shape between NPs, that govern the complex phenomenon of cellular NP uptake. For 
traditional chemicals, effects are therefore related to exposure concentration expressed 
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as mass per volume. This dose metric is also practical and convenient for NPs. For soluble 
chemicals the total applied mass translates to a defined number of ‘subunits’, e.g. atoms or 
molecules, reacting with a cell or the cell surface (receptors). Although NPs are also 
composed of ‘subunits’, only part of the mass exposed at the NP surface is able to interact 
with the membrane for uptake. Due to the increasing surface to volume ratio with 
decreasing NP size, the portion of mass able to interact differs for the same mass of NPs of 
different sizes. Therefore, a dose in mass translates in different doses of ‘subunits’ 
interacting with the cell membrane for NPs. As a result, there is an ongoing discussion 
about the most appropriate dose metric with regard to toxicology, also dependent on the 
endpoint under investigation [6]. Up to today it remains unclear whether the same mass, 
the same number, the same volume, or the same surface area of NPs represents the 
proper dose metric for comparison between NPs of different sizes.
 The dose metric of studies used in this thesis vary. While some studies are based on 
the application of the same number of NPs, other researchers expose cells to the same 
mass of NPs. Since the appropriate dose metric had not been identified yet, we chose to 
expose cells to the same mass of NPs, the more common dose metric (Chapter 3, Chapter 
4). This also enabled comparison with already published data.
 Comparison of uptake rates of various studies (Chapter 6) covers publications on both 
dose metrics. Especially in case of phagocytosing cells the majority of researchers applied 
the same mass of NPs. In case of non-phagocytosing cells, the data collected from 
literature cover both dose metrics about equally often.  A dose metric can only be applied 
to studies that compare different NP sizes. For the largest group of studies, no dose metric 
can be assigned. These study address either only one NP type, the same NP type in 
different cell lines, or different NP concentrations within one cell line.
 Having noticed these differences, the question arises whether differences in dose 
metrics might cause differences in observed uptake rates and variability within the 
constructed QSARs. The range of uptake rates for studies based on the same number of 
NPs is smaller than for mass-based studies (Figure 6.2, Chapter 6). Yet, the range of uptake 
rates for mass based exposure is similar to those where no metric can be applied. 
Therefore, variability in uptake rates can be most likely attributed to other differences 
between studies, as will be further discussed in this chapter.
 Understanding NP uptake kinetics in a quantitative way, as intended with this thesis, 
is a prerequisite to draw meaningful conclusion about nanotoxicology. Instead of 
evaluating in vitro (toxicity) test results based on exposure doses, the NP dose actually 
taken up by a cell, and therefore reaching intracellular targets, needs to be considered. 
Ideally, toxicological studies would report the number of NPs reaching the relevant target, 
e.g. a cellular sub-compartment. Problems related to the determination of the intracellular 
NP concentration are discussed in the next section.
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Determination of intracellular NP concentration
To reach the goal of a quantitative description of NP uptake, the detection of the 
intracellular particle concentration ideally needs to be improved. Many of the collected 
studies determined uptake via the measurement of the fluorescence intensity signal of 
marked NPs, as it is inexpensive and only requires common instruments. The fluorescence 
intensity is assumed to be proportional to the particle number per cell. Yet, fluorescence 
intensity cannot be used as absolute value for the particle number, as the images only 
show a cross section of one cell, i.e. one does not determine the fluorescence of all NPs 
inside one cell [7]. In addition, different methods may be applied to determine the 
fluorescence of single NPs and that of cells which took up NPs, e.g. microscopy and flow 
cytometry. The fluorescence detected by different methods cannot be related to each 
other [8]. Fluorescence intensity measured by flow cytometry can be normalized to 
particles of different intensities. However, they cannot be related to actual numbers [8] 
due to difficulties in the creation of calibration curves; the amount inside of the cells might 
not be linear in fluorescence as outside of cells [9]. Therefore, it is not possible to convert 
the fluorescence signal into an absolute measurand. Comparison of absolute amounts of 
material taken up are therefore not possible.
 Chapter 3 indicated that uptake rates of AgNPs into 16HBE14o-cells were higher for 50 
nm particles when expressed in mass, but highest for 20 nm particles on number-basis. It 
stresses the importance of absolute values for NP uptake in order to convert one 
measurand to another. Our results thus show that not just the uptake expressed as mass 
should be considered but also the conversion to NP numbers (and vice versa) might need 
to be considered when studying the mechanism of uptake phenomenon and related 
fields in order to determine relationships.
 Absolute amounts can be detected by a very sensitive detection method called high 
resolution inductively coupled plasma mass spectrometry (HR-ICP-MS) as applied in 
Chapter 3, Chapter 4, and Chapter 5. This method was improved by coupling to an 
asymmetric flow field fractionation (AF4) to allow for separation of NPs in the supernatant 
according to size and subsequent determination of their abundance (Chapter 5). This 
newly developed method allows to study particle dissolution or aggregation in the 
exposure medium during the time course of the experiment. Combination of the total 
uptake of silver by cells and analysis of the remaining silver in the exposure medium allows 
one to determine the recoveries. The advantages are applicability to low exposure 
concentrations of 10 µg/mL and very high sensitivity, as well as the determination of NP 
stability. Unfortunately the method is expensive and time intensive as the method needs 
adjustment for each NP. It was therefore only possible to determine silver concentrations 
in the supernatant of few samples.
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Particle concentration
The amount of NPs that cells are exposed to, expressed in either dose metric, is variable 
across studies largely due to different desired outcomes of studies and available detection 
techniques. While it might be necessary to expose cells to rather high NP concentrations 
in order to study and understand toxicological mechanisms, risk assessment should be 
based on realistic exposure concentrations. Yet, concentrations in uptake studies reach up 
to 100 µg/mL [10], a manifold of the expected environmental concentration of 8.8·10-5-0,01 µg/
mL [11]. We chose the highest expected environmental concentration of 0.01 µg/mL as 
the exposure concentration for our uptake studies (Chapter 3, Chapter 4). With respect to 
the origin of the studied cell lines, namely the lung, realistic exposure concentrations for 
short-term exposure via inhalation might also be of interest. Such exposure concentrations 
are estimated to be a factor of 10 higher than our chosen exposure concentration [12].
 Further complexity is added due to possible differences in the exposure concentration 
and the amount of particles reaching the cells, which are usually positioned at the bottom 
of a cell culture plate. Cho et al. found uptake to be higher for cells in the upright 
configuration, so cells positioned at the bottom of a culture disc in comparison to the 
inverted configuration [13]. The observed effect was more pronounced for larger and 
therefore heavier NPs. This effect can be explained by the occurrence of sedimentation. 
The fraction between the added amount of NPs and those actually reaching the bottom 
of in vitro test systems, and therefore coming into contact with cells, can be estimated via 
a computational model [14]. This model takes sedimentation and diffusion of particles in 
the test medium into account. It requires thorough characterization of the NPs within the 
respective exposure medium.
 The effect of NP exposure concentration on cellular uptake (kinetics) remains an 
open question based on currently available data. It has been shown that higher exposure 
concentrations lead to increased uptake after a fixed time point.  A maximum exposure 
concentration exists after which no further increase in the maximum intracellular 
concentration is observed. Higher exposure concentrations also lead to increased uptake 
rates [15-22].  In addition, slopes differ between cell lines [21]. The observed differences 
might be caused by differences in the available cell membrane surface area for particle 
wrapping, the time needed to produce new membrane/membrane recycling, and cell 
volume, as well as the amount of certain cell surface receptors. These properties go along 
with the biological function of different cell types. Therefore, it is highly desirable to 
include additional information about the cells in which uptake is determined, as explained 
also in more detail later on. As discussed, improved detection of the intracellular particle 
concentration will aid to determine the relationship of NP exposure concentration and 
uptake amounts.
131
7
General discussion
Exocytosis
The so called mechanism of exocytosis is an active mechanism to transport (nanoparticulate) 
substances out of a cell. Exocytosis has been observed in form of decreasing intracellular 
NP concentrations when the NP in the exposure medium have when removed [10, 15, 23, 24]. 
This elimination mechanism might be responsible for the observed leveling off of uptake 
curves. Exocytosis might be the rate limiting factor of NP uptake leading to steady state.
 Traditional chemicals that enter cells or organisms by facilitated diffusion, as well as 
NPs, show increased uptake rates with increasing exposure concentrations, but their 
transport rates reach a maximum. In case of facilitated diffusion, it is the number of carriers 
that can be occupied that limit further uptake. For NPs it is likely the amount of available 
cell surface area for the formation of endocytic vesicles and the speed at which new 
membrane can be produced.
 In order to take endocytosis into account in our work, we calculated parameters for 
first order uptake kinetics according to a one compartment model that includes a 
parameter k for elimination (Chapter 3, Chapter 4, and Chapter 6). The obtained uptake 
rates describe simultaneous uptake and elimination. Further studies are needed to 
determine how long NPs stay in cells, to what extend they are removed and which factors 
determine their removal. The degree of exocytosis of a non-degradable NP is very 
important with regard to bioaccumulation.
Size and charge determination
Our literature review showed that NP size is one of the most studied NP property with 
regard to effects on cellular uptake and first findings supported the hypothesis that a size 
optimum for NP uptake exists (Chapter 2). The similarity of NP size to biomolecules [25] 
and viruses [26, 27] resulted in a strong focus on this NP property. Particle size, particle 
density, agglomeration state and agglomerate characteristics may change when NPs are 
added to cell culture medium in comparison to stock solutions. The NPs’ charge as well as 
size can be strongly influenced by the surrounding medium [28, 29]. These effects can 
cause large differences in the size of NPs that the cells ‘see’. A critical step for interpretation 
of uptake (and toxicological) studies is the characterization of the studied NP in the 
relevant matrix to which it is added. It is important to include critical NP characterization 
prior to and also after mixing with biological media. Characterization should focus on the 
physical properties such as aggregation and surface charge. Additional detection of the 
thickness and composition of adsorbed protein corona would be beneficial. If the size of 
NPs in the medium of exposure and changes in size over time are not considered and 
reported, interpretation of data about NPs uptake (and toxicity) become difficult to 
impossible. In order to understand the influence of NP properties, experimental conditions 
and cell lines on uptake kinetics and possible accumulation, the starting material, here the 
NPs and the experimental settings, need to be fully understood, characterized and 
reported. Otherwise, effects cannot be attributed to one certain factor.
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As these characterizations are sometimes not reported in the relevant matrix, we assumed 
the concept of primary particle size to be valid in the publications under investigation for 
the construction of QSARs. As the concept of primary particle size may not be relevant 
due to aggregation and ageing occurring in the medium, the lack of this information 
results in a limitation of our model. Due to the limited number of available uptake studies 
containing kinetic information, it was not possible to leave those studies out that lack NP 
characterization in the relevant media. 
 In our own uptake studies it became clear that it is not always easy to obtain NP size 
characteristics as available instrumentation is not always suitable for size detection under 
given conditions. Dynamic light scattering is an often applied method, yet it is not suitable 
for the size determination of small NPs with rather low concentrations [30]. Centrifugal 
particle sedimentation as a second widely applied methods led to unreproducible results 
in our experiments.
 This demonstrates the large discrepancy between requirements for the construction 
of predictive models, as well as interpretation of uptake and toxicity studies, and the 
available means. To evaluate whether the concept of primary particle size remains valid 
under given conditions, easy to use, inexpensive and sensitive detection methods need to 
be developed. Ideally, they would applicable at low, environmental relevant NP 
concentrations. One step in this direction was taken at Philips Innovation Services (Chapter 
5). The developed method has been shown to allow for the determination of AgNPs 
stability via the detection of their size in the exposure medium over time, as well as their 
abundance even at low NP concentrations of 10 µg/mL.
 Similar to size, charge can also be altered drastically when the surrounding medium 
changes. This is especially the case when NPs are added to serum containing cell media. 
The presence of proteins can influence charge, as well as size, and in turn also uptake, due 
to the formation of a so called protein corona. Charge of NPs of the same material may 
already be variable in stock solution (Chapter 3, Chapter 4) and the observed effect might 
not be only caused by differences in size. The determination of the zeta potential requires 
higher concentrations than used for our experiments. The determination of the zeta 
potential under given conditions was therefore not possible [31]. Overall, technical 
limitations are a major factor that limit systematic studies under environmental relevant 
concentrations that would close some knowledge gaps.
Cell line
As mentioned earlier, it is desirable to include more information about the cell line under 
investigation than it is common in publications nowadays. In order to be able to 
harmonize/normalize published data for modeling purposes it would be beneficial if 
information about cell sizes, surface area and cell volume would be reported. Wilhelm et 
al. show that the total NP load per cell is the same when normalized to the cell surface area 
[20]. The NP binding capacity is proportional to the surface area across different cell lines, 
133
7
General discussion
yet the characteristic time needed for NP internalization differs between cell lines [32]. 
Therefore, according to Wilhelm and Gazeau, the total amount of NPs that can be taken up 
can be predicted by the cells surface area, but the time needed to achieve this maximum 
will vary. This contradicts our findings that uptake into 16HBE cells is approximately twice 
as high as for THP-1 cells besides the similar cell culture dish surface area covered with cells 
as determined by microscopic inspection. These differences might be explained by other 
factors such as intended biological role of the cell line and expression of different cell 
surface receptor (amounts), as discussed in Chapter 2 in detail.
Protocolling
Regretfully, there is also a strong need for the improvement of quality of published data. 
Fundamental information for the interpretation of results is sometimes lacking. This 
includes the number of exposed cells, NP concentrations and volumes/numbers applied, 
as well as information to convert data given in one measurand to another, e.g. molecular 
mass or the length of the edge of a unit cells in order to convert mass to NP numbers. The 
latter is of special importance when working with self-made NPs of commonly unknown 
composition and does not represent any obstacles when working with silver like we did. 
To improve protocolling we placed importance on the description of the experimental 
design, reporting not only NP concentrations but also applied volumes, the number of 
exposed cells and well size. To this end, the provision of NP standards with defined 
properties and formats for standardized test protocols would greatly improve the further 
use of studies.
Conclusions
In light of these considerations, we conclude the following: 
Size is an important determinant for NP uptake (kinetics) when looking at one uptake 
study at a time (Chapter 2-4). Results of Chapter 6 contradict these findings; size and 
uptake kinetics do not correlate when comparing various studies due to observed 
differences of uptake kinetics for the same NP size in dependence of exposure 
concentration and cell line.
 Similarly, charge was found to play an important role in NP uptake (kinetics) when 
looking at one study at a time (Chapter 2). Higher charges lead to higher uptake in 
comparison to less charged NPs. Positively charged NPs are taken up faster than negatively 
charged ones when the absolute zeta potential is comparable. In contrast, comparison of 
descriptors of uptake kinetics across various studies do not show a correlation between 
NP charge and uptake rates (Chapter 6).
 Despite the availability of a quite large data set of studies on the effect of NP 
properties and experimental conditions on NP uptake, the constructed model (Chapter 6) 
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is considered preliminary. This is due to differences in uptake rates for different exposure 
concentrations and differences in cell lines, such as available cell surface area or cell 
volume. Up to now it is not possible to take exposure concentration and cell line effects 
into account in modeling. Improved models require normalization between studies and 
experimental conditions. This is not possible up to today due to a lack of systematic 
studies on concentration and cell (size) effects on NP uptake kinetics.
 Overall, accumulation of NPs appears similar to that of traditional chemicals in terms 
of observed leveling off of uptake curves. While it is the increased elimination of traditional 
chemicals as a function of time that causes the leveling off, leveling off is likely limited by 
the rate of production and/or recycling of cell membrane needed to form endocytic 
vesicles in case of NPs. Similar to traditional chemicals, uptake of NPs into cells also follows 
first order kinetics.
 For traditional chemicals and NPs high concentrations in the medium lead to high 
concentrations in the cell. Yet, in contrast to traditional chemicals that diffuse through 
membranes at a rate that increases linearly with the exposure concentration, NPs show 
saturation of the net transport rate due to either decreased uptake or increased elimination. 
Similar to traditional chemicals taken up by carriers/channels, NPs show saturation of the 
transport rate in dependence of the concentration of chemical in the exposure medium. 
While it is the limited number of carrier proteins for traditional chemicals, it is likely the 
available cell surface area that can be used to form endocytic vesicles in case of NPs.
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Summary
Summary
Introduction (Chapter 1)
The aim of this thesis was to gain a better understanding of NP properties and experimental 
conditions that determine cellular NP uptake in order to construct a model to describe 
property-effect relationships. In contrast to traditional chemicals that enter cells or organisms by 
passive diffusion, most NPs are taken up by cells via active uptake mechanisms. Therefore, 
this type of emerging chemicals requires new models that take this active mechanism 
into account. Predictive quantitation of the extent of NP uptake by living cells will enable 
inexpensive and easy risk assessment of NPs. Relating NP uptake kinetics to easily 
measurable NP properties can help to overcome the obstacle that not every NP type can 
be tested for their biological effects separately. On the long run such a correlation 
facilitates prioritization for toxicity and bioaccumulation testing and allow for the safe 
implementation of nanotechnology.
Nanoparticle properties and experimental conditions determining 
cellular nanoparticle uptake (Chapter 2)
A literature review was conducted to determine important factors for NP uptake. This 
resulted in an inventory of publications that determined the effect of NP properties such 
as size, charge, aspect ratio, core material, and surface modification and of experimental 
conditions such as cell type and medium composition on cellular, in vitro NP uptake. NP 
size, charge and medium composition (presence or absence of proteins) are the most well 
studied factors. We describe emerging patterns, such as the 50 nm size optimum and 
lower uptake for less charged NPs. We found NP size to play a critical role in the extent of 
uptake but also in uptake kinetics. We point to contradictory results and explain their 
possible causes. We give recommendations to overcome some of the observed obstacles, 
to fill knowledge gaps and resolve apparent contradictions.
Uptake kinetics of differently sized nanoparticles into 16HBE-14o cells 
(Chapter 3)
Having identified size as the probably most important determinant of uptake, we then 
explored the effect of NP size and medium composition on uptake kinetics into two 
different types of cells (Chapter 3, Chapter 4). 16HBE-14o cells, capable of the fundamental 
mechanism of endocytosis, took up 50 nm NPs to the largest extend in absence of FCS on 
mass basis. This proposed uptake optimum shifted towards 20 nm NPs when uptake was 
expressed as NP numbers. These results stress the importance of the measurand in which 
results of NP uptake studies are presented.
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Uptake kinetics of differently sized nanoparticles into THP-1 cells  
(Chapter 4)
For comparison between different cell lines similar uptake studies, to those with 16 HBE- 
cells under environmental relevant exposure concentrations, were conducted with THP-1 
cells. Macrophages are part of the immune system against invading cells and foreign 
agents including NPs. These cells have a special uptake mechanism called phagocytosis. 
The upper size limit for phagocytosis is approximately 10 µm. Therefore, they differ 
significantly from 16HBE-14o cells. Besides their importance as the first line of defense in 
organism, there is a considerable lack of NP uptake studies in this cell type. We, therefore, 
determined uptake rates for three NP sizes (20, 50, and 75 nm) in medium with and without 
FCS. Uptake in absence of FCS was higher than in the presence of FCS. In contrast to 
16HBE-14o cells, THP-1 cells took up the 20 nm NPs faster in absence of FCS on mass basis 
than the larger NPs.
Method development to determine NP dissolution during the 
experiments (Chapter 5)
For uptake as well as toxicity studies, the size of NPs within a certain exposure medium 
over time is of great importance, especially for possibly dissolving NPs such as AgNPs. This 
is necessary to determine whether observed (toxic) effects might be caused by dissolution 
and the release of toxic ions. Therefore, a new method was developed to determine the 
stability and the abundance of Ag nanoparticles in the supernatant after cell exposure at 
different timings. Asymmetric flow field flow fractionation (AF4) allows for the size 
dependent particle separation. On-line hyphenation to the sensitive elemental detection 
by ICPMS results in the determination of the abundance of AgNPs of a certain size. 
Dissolution of 75 nm AgNPs in cell culture medium without FCS is much faster than in 
medium supplemented with FCS. The developed method is an important tool to study 
NP size/dissolution over time in in vitro test systems.
Exploring the possibility of read-across via QSARs on the extent of 
nanoparticle uptake into living cells (Chapter 6)
While fast and inexpensive risk assessment of the ever increasing number of NPs is needed, 
no general approach to modelling of uptake kinetics has been developed. We therefore 
tested whether cellular nanoparticle uptake follows first-order kinetics. This was indeed 
the case across different nanoparticles, cell lines and experimental conditions. Next, we 
determined whether the values of the parameters of first-order kinetics can be correlated 
to easily measurable NP properties such as size or charge to derive QSARs. Unfortunately, 
neither nanoparticle size nor charge correlated well with the parameters of first-order 
kinetics. This is probably caused by the heterogeneity of published data. Other factors 
such as exposure concentration and cell properties seem to be more important 
determinants of NP uptake. As a result, we give recommendations which information 
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should be included in future studies to prevent the piling up of data that cannot be 
incorporated into models with increased predictive power.
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Introductie (Hoofdstuk 1)
Het doel van dit proefschrift was het verkrijgen van inzicht in de eigenschappen van 
nanodeeltjes en experimentele condities die bijdragen aan de cellulaire opname van 
nanodeeltjes om een model op te kunnen stellen die eigenschap-effect relaties beschrijft. 
In tegenstelling tot traditionele stoffen, die cellen of organismen binnenkomen door 
passieve diffusie, worden de meeste nanodeeltjes door cellen opgenomen middels een 
actief opnamemechanisme. Om deze reden is er behoefte aan nieuwe modellen, die 
rekening houden met dit type mechanisme. Het kwantitatief voorspellen van de mate 
waarin nanodeeltjes worden opgenomen in levende cellen maakt goedkope en 
eenvoudige risicobeoordeling mogelijk. Daarbij kan het relateren van de kinetiek van 
nanodeeltjes aan hun eigenschappen helpen bij het overwinnen van het feit dat niet elk 
type nanodeeltje apart getest kan worden op biologische effecten. Op de lange termijn 
kan een correlatie als deze bijdragen aan de prioritering van stoffen gebaseerd op toxiciteit 
en bioaccumulatie en zorgen voor een veilige implementatie van nanotechnologie. 
Chemische eigenschappen en experimentele condities die bijdragen aan 
cellulaire opname van nanodeeltjes (Hoofdstuk 2)
Een literatuurstudie is uitgevoerd om de belangrjste factoren gerelateerd aan de opname 
van nanodeeltjes te bepalen. Deze resulteerde in een inventarisatie van publicaties die het 
effect van eigenschappen van nanodeeltjes, waaronder grootte, elektrische lading, aspect 
ratio, kernmateriaal en oppervlakkige modificaties, en van experimentele condities, zoals 
celtype en mediumcompositie, op cellulaire in vitro opname van nanodeeltjes beschrijft. 
De grootte van nanodeeltjes, elektrische lading en de compositie van het medium (de 
aan- of afwezigheid van eiwitten) bleken de best bestudeerde factoren. We beschrijven 
patronen die naar voor komen, zoals het 50 nm optimum en de lagere opname van 
nanodeeltjes met een lager elektrisch potentiaal. De grootte van het nanodeeltje blijkt 
een kritische rol te spelen in zowel de mate van opname, als de opnamekinetiek. Verder 
wijzen wij op tegenstrijdige resultaten en gaan wij in op de mogelijke oorzaken. Tenslotte 
geven wij aanbevelingen om enkele van de waargenomen obstakels te overwinnen, 
kenniskloven te dichten en ogenschijnlijke tegenstrijdigheden op te lossen.
Opnamekinetiek van nanodeeltjes van verschillende groottes in 
16HBE-14o cellen (Hoofdstuk 3)
Na het identificeren van grootte als (waarschijnlijk) de belangrijkste factor voor opname, 
onderzochten wij het effect van nanodeeltjesgrootte en mediumcompositie op de opname- 
kinetiek in twee celtypen (Hoofdstuk 3, Hoofdstuk 4). In 16HBE-14o cellen, die in staat zijn 
tot fundamentele endocytose, werden 50nm-deeltjes bij de afwezigheid van FCS op 
gewichtsbasis in de grootste mate opgenomen. Dit voorgestelde opname- optimum 
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schoof echter naar 20nm-deeltjes wanneer opname werd uitgedrukt in aantallen deeltjes. 
Deze resultaten benadrukken dan ook het belang van de manier waarop nano deeltjes-
opname wordt uitgedrukt.
Opnamekinetiek van nanodeeltjes van verschillende groottes in  
THP-1 cellen  (Hoofdstuk 4)
Om een vergelijking te kunnen trekken tussen verschillende cellijnen zijn opname- 
experimenten, uitgevoerd op 16HBE-cellen, herhaald op THP-1 cellen. Macrofagen zijn 
onderdeel van het immuunsysteem tegen binnendringende lichaamsvreemde cellen, 
waaronder nanodeeltjes. Deze cellen maken gebruik van een speciaal opnamemechanisme, 
fagocytose genaamd. De bovengrens voor fagocytose is vastgesteld op ongeveer 10 µm, 
wat significant afwijkt van 16HBE-14o cellen. Naast het belang van deze cellen als eerstelijns 
 afweermechanisme in organismen is er een aanzienlijk gebrek aan onderzoek aan de 
opname van nanodeeltjes in dit celtype. Om deze reden hebben wij voor drie verschillende 
deeltjesgroottes (20, 50, and 75 nm) de mate van opname vastgesteld in medium met en 
zonder FCS. De deeltjesopname was hoger in afwezigheid van FCS dan in het medium 
met FCS. 20nm-deeltjes werden sneller opgenomen in THP-1 cellen in afwezigheid van 
FCS (op gewichtsbasis) dan grotere deeltjes: Dit in tegenstelling tot 16HBE-14o cellen.
Methodeontwikkeling om desintegratie van nanodeeltjes tijdens 
experimenten te bepalen (Hoofdstuk 5) 
In zowel opname- als toxiciteitsstudies speelt de grootte van nanodeeltjes in een bepaald 
blootstellingsmedium over tijd een belangrijke rol, zeker wanneer het potentieel oplosbare 
deeltjes betreft, zoals Ag-nanodeeltjes (nanozilver). Het is van belang om te bepalen of 
de waargenomen (toxische) effecten mogelijkerwijs veroorzaakt zijn door desintegratie 
en het vrijkomen van toxische ionen. Een nieuwe methode is ontwikkeld om op diverse 
tijdstippen de stabiliteit en abundantie van nanozilver te bepalen in het supernatant 
nadat de cellen zijn blootgesteld. Asymmetrische-stroom-veldstroomfractionering (AF4) 
zorgt voor grootte-afhankelijke separatie van nanodeeltjes. Deze techniek, gekoppeld aan 
analyses middels ICPMS resulteert in het vaststellen van de abundantie van nanozilver 
van een bepaalde grootte. De desintegratie van deeltjes nanozilver van 75 nm in een 
celcultuurmedium zonder FCS verliep veel sneller dan in een medium verrijkt met FCS. 
De ontwikkelde methode is een belangrijk hulpmiddel in het bestuderen van nano-
deeltjesgrootte/desintegratie over tijd in in vitro testsystemen.
147
Samenvatting
Het verkennen van de mogelijkheid tot “read-across”-aanpak via QSARs 
met betrekking tot de mate van opname van nanodeeltjes in levende cellen 
(Hoofdstuk 6) 
Terwijl snelle en goedkope risicobeoordeling van nanodeeltjes nodig is, bestaat er nog 
geen algemene aanpak met betrekking tot het modelleren van opnamekinetiek. Om deze 
reden hebben wij getest of de cellulaire opname van nanodeeltjes wordt gekenmerkt 
door eersteordekinetiek. Dit was inderdaad het geval voor meerdere nanodeeltjes, 
cellijnen en experimentele condities. Hierop volgend hebben wij bepaald of de parameters 
gerelateerd aan eersteordekinetiek gecorreleerd kunnen worden aan makkelijk meetbare 
eigenschappen van nanodeeltjes, zoals grootte of elektrische lading, met als doel het 
opstellen van QSARs. Helaas bleek noch de deeltjesgrootte, noch de elektrische lading 
gecorreleerd te zijn aan deze parameters, wat hoogstwaarschijnlijk is veroorzaakt door 
de heterogeniteit in gepubliceerde data. Andere factoren, zoals de blootstellings-
concentratie en celeigenschappen, lijken belangrijkere determinanten voor de opname 
van nanodeeltjes. Als gevolg hiervan geven wij aanbevelingen met betrekking tot welke 
informatie studies in de toekomst moeten bevatten. Dit om de ophoping van data te 
voorkomen, die niet gebruikt kunnen worden in modellen.
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